Check out the online TTS 2024 Program

Time	Room	Session
07:00 - 08:00 \| Early Morning Sessions
07:00-08:00	11	11 07:00 Invited Symposia: Eplet Matching: Hype or the Way to the Transplant Lasting a Lifetime – A Debate Full Details Peter Nickerson, Canada Pro Peter Nickerson, Canada Pro Anat Tambur, United States Con Anat Tambur, United States Con
07:00-08:00	25	25 07:00 Invited Symposia: Stopping the Inevitable? Approaches to Respiratory Viruses Full Details Michael Ison, United States Exploring the Therapeutic Pipeline for Respiratory Viruses Michael Ison, United States Exploring the Therapeutic Pipeline for Respiratory Viruses Victoria Hall, Canada Update on Vaccinations to Prevent Respiratory Viral Infections Victoria Hall, Canada Update on Vaccinations to Prevent Respiratory Viral Infections Nancy Law, United States Pre-Exposure and Post-Exposure Prophylaxis for Respiratory Viruses Nancy Law, United States Pre-Exposure and Post-Exposure Prophylaxis for Respiratory Viruses
07:00-08:00	4	4 07:00 Invited Symposia: Recurrent Glomerular Disease Post Kidney Transplant: Navigating the New Landscape, New Frontiers in FSGS, and Membranous Nephropathy, Session I Full Details Leonardo Riella, United States The Changing Landscape and Understanding of Recurrent Glomerular Disease After Kidney Transplantation Leonardo Riella, United States The Changing Landscape and Understanding of Recurrent Glomerular Disease After Kidney Transplantation Mireille El Ters, United States Membranous Nephropathy Post Kidney Transplant Mireille El Ters, United States Membranous Nephropathy Post Kidney Transplant Nada Alachkar, United States FSGS-Recurrence: Latest Advances in Genetic Screening, Novel Immunosuppressive Strategies, Precision Approaches Nada Alachkar, United States FSGS-Recurrence: Latest Advances in Genetic Screening, Novel Immunosuppressive Strategies, Precision Approaches
07:00-08:00	155	155 07:00 Invited Symposia: Overcoming Structural and Societal Barriers to Organ Donation Full Details Sanjay Nagral, India What Steps Need to Be Taken to Advance Equitable Deceased Donor Transplant in India? Sanjay Nagral, India What Steps Need to Be Taken to Advance Equitable Deceased Donor Transplant in India? Elmi Muller, South Africa Travelling for Transplant - How to Provide Care for Recipients and Donors Who Travel for Transplantation Elmi Muller, South Africa Travelling for Transplant - How to Provide Care for Recipients and Donors Who Travel for Transplantation Axel Rahmel, Germany Deceased and Living Donation in Europe - Which Countries Are Making Progress and Why ? Axel Rahmel, Germany Deceased and Living Donation in Europe - Which Countries Are Making Progress and Why ?
07:00-08:00	10	10 07:00 Invited Symposia: Tell Me More About That: How to Do Qualitative Research in Transplantation Full Details Karen Vanterpool, United States Designing, Conducting, and Publishing Qualitative Interview Studies Karen Vanterpool, United States Designing, Conducting, and Publishing Qualitative Interview Studies Rachel Patzer, United States The Future of Qualitative Research in the Era of AI Rachel Patzer, United States The Future of Qualitative Research in the Era of AI Elisa Gordon, United States Best Papers in Transplant Qualitative Research Elisa Gordon, United States Best Papers in Transplant Qualitative Research
07:00-08:00	22	22 07:00 Invited Symposia: Exploring the Immune Impact of Frailty and Aging on Solid Organ Transplant Recipients Full Details Jennifer Lai, United States Effect of Physical Frailty and Aging on Recipient Outcomes in Solid Organ Transplantation Jennifer Lai, United States Effect of Physical Frailty and Aging on Recipient Outcomes in Solid Organ Transplantation Joanna Schaenman, United States Frailty and Its Association with Immune Dysfunction in Transplant Recipients Joanna Schaenman, United States Frailty and Its Association with Immune Dysfunction in Transplant Recipients Stefan Tullius, United States Impact of Immune Aging and Senescence on the Generation of the Alloimmune Response of Solid Organ Transplant Recipients Stefan Tullius, United States Impact of Immune Aging and Senescence on the Generation of the Alloimmune Response of Solid Organ Transplant Recipients
07:00-08:00	154	154 07:00 Invited Symposia: Highway Guardrails: Organ Transplantation with Kidney Safety Net Full Details Giselle Guerra, Brazil Preventing Highway Robbery: Kidney Transplant Perspective on Safety Nets Giselle Guerra, Brazil Preventing Highway Robbery: Kidney Transplant Perspective on Safety Nets Mark Russo, United States Highway to Heaven: Kidney Utilization and Outcome after Liver Transplant Mark Russo, United States Highway to Heaven: Kidney Utilization and Outcome after Liver Transplant Shelley Hall, United States On the Road Again: The Journey of Heart Kidney Transplant and Safety Net Timing Shelley Hall, United States On the Road Again: The Journey of Heart Kidney Transplant and Safety Net Timing
07:00-08:00	24	24 07:00 Invited Symposia: Ancestry-Specific Variation in the Apolipoprotein L1 Gene (APOL1) and Kidney Transplant Outcomes Full Details Barry Freedman, United States Overview of the Current Status of the NIH Study 7 Years Later Barry Freedman, United States Overview of the Current Status of the NIH Study 7 Years Later Krista Lentine, United States Exploring Solutions to Ethical Challenges of APOL-1 Testing Krista Lentine, United States Exploring Solutions to Ethical Challenges of APOL-1 Testing Chi-Yuan Hsu, United States Living Donor Extended Time Outcomes (LETO Study) Chi-Yuan Hsu, United States Living Donor Extended Time Outcomes (LETO Study) Akinlolu Ojo, United States APOL1 Bi and Monoallelic Variants and Chronic Kidney Disease in West Africans Akinlolu Ojo, United States APOL1 Bi and Monoallelic Variants and Chronic Kidney Disease in West Africans
07:00-08:00	9	9 07:00 Invited Symposia: Current Status of Uterus Transplantation Full Details Kathleen O'Neill, United States Cost-Effectiveness of Uterine Transplant Versus Other Pathways to Parenthood Kathleen O'Neill, United States Cost-Effectiveness of Uterine Transplant Versus Other Pathways to Parenthood Liza Johannesson, United States Uterus Transplantation - Current State and Future Application Liza Johannesson, United States Uterus Transplantation - Current State and Future Application Ann Kataria, United States Unique Aspects of the Immune Response in Uterus Transplantation Ann Kataria, United States Unique Aspects of the Immune Response in Uterus Transplantation
07:00-08:00	12	12 07:00 Rapid Fire Oral Abstract Session: Fundamentals of Transplantation Science Full Details Joe Douglas, United States Use of BMT CTN 1202 Study Samples to Identify Prognostic Biomarkers for Chronic Graft-versus-Host Disease with Peripheral Blood Hematopoietic Cell Transplant Recipients Joe Douglas, United States Use of BMT CTN 1202 Study Samples to Identify Prognostic Biomarkers for Chronic Graft-versus-Host Disease with Peripheral Blood Hematopoietic Cell Transplant Recipients Chengguo Wei, United States Genetic Polymorphisms of LILRB3 Drive Monocyte-Mediated Inflammation in Acute Kidney Injury Chengguo Wei, United States Genetic Polymorphisms of LILRB3 Drive Monocyte-Mediated Inflammation in Acute Kidney Injury Chao Yang, People's Republic of China Integrated Multi-Omics and Murine Models Identify CSF1 as a Therapeutic Target in Chronic Allograft Rejection Following Kidney Transplantation Chao Yang, People's Republic of China Integrated Multi-Omics and Murine Models Identify CSF1 as a Therapeutic Target in Chronic Allograft Rejection Following Kidney Transplantation Sara Kazeminia, United States Synergistic Effects of MKK4 Inhibitor and Ex Vivo Gene Therapy on Liver Regeneration in a Porcine Model of FAH Deficiency: Progress Towards Human Liver Production in Chimeric Pigs Sara Kazeminia, United States Synergistic Effects of MKK4 Inhibitor and Ex Vivo Gene Therapy on Liver Regeneration in a Porcine Model of FAH Deficiency: Progress Towards Human Liver Production in Chimeric Pigs Mustafa Nazzal, United States The Use of Nanocomposite Materials Tagged with Deferoxamine to Facilitate Iron Chelation and Mitigation of Ferroptosis and Ischemia Reperfusion Injury of Livers Using Novel Normothermic Perfusion Pump Mustafa Nazzal, United States The Use of Nanocomposite Materials Tagged with Deferoxamine to Facilitate Iron Chelation and Mitigation of Ferroptosis and Ischemia Reperfusion Injury of Livers Using Novel Normothermic Perfusion Pump Ramiah Caine, United States Single-Cell RNA/TCR Sequencing: Do Urinary CD8+ T Cell Populations Accurately Reflect Transcriptional Profiling of Allograft Infiltrating CD8+ T Cell Populations? Ramiah Caine, United States Single-Cell RNA/TCR Sequencing: Do Urinary CD8+ T Cell Populations Accurately Reflect Transcriptional Profiling of Allograft Infiltrating CD8+ T Cell Populations? Sandra Lindstedt, Sweden Exogenous Mitochondrial Therapy during Machine Perfusion Restores the Function of Livers Donated After Circulatory Death A Cross-Circulation Evaluation for Clinical Transplantability Sandra Lindstedt, Sweden Exogenous Mitochondrial Therapy during Machine Perfusion Restores the Function of Livers Donated After Circulatory Death A Cross-Circulation Evaluation for Clinical Transplantability
07:00-08:00	20	20 07:00 Rapid Fire Oral Abstract Session: Hot Topics in Heart Transplantation Full Details David D'Alessandro, United States Heart Transplantation from Donation After Circulatory Death Donors: Comparison of the OCS Heart and Non-OCS Methods David D'Alessandro, United States Heart Transplantation from Donation After Circulatory Death Donors: Comparison of the OCS Heart and Non-OCS Methods Yasuhiro Shudo, United States Over 1,000 Heart Transplants Using Donation After Circulator Death (DCD) Donors: Real-World Experience with the Organ Care System (OCS) Heart Yasuhiro Shudo, United States Over 1,000 Heart Transplants Using Donation After Circulator Death (DCD) Donors: Real-World Experience with the Organ Care System (OCS) Heart Vincent Mauduit, United States Large Heart Transplant Meta-Analysis Reveals Several New Genetic Associations with Post-Transplant Outcomes Vincent Mauduit, United States Large Heart Transplant Meta-Analysis Reveals Several New Genetic Associations with Post-Transplant Outcomes Achilles Aiken, United States Outcomes of C1q Positive De Novo Donor-Specific Antibodies Following Heart Transplantation Achilles Aiken, United States Outcomes of C1q Positive De Novo Donor-Specific Antibodies Following Heart Transplantation Jeremy Birkmire, United States A Novel Donor-Recipient Risk Index to Predict Short-Term Outcomes in Pediatric Heart Transplantation Jeremy Birkmire, United States A Novel Donor-Recipient Risk Index to Predict Short-Term Outcomes in Pediatric Heart Transplantation Jon Kobashigawa, United States Does the Binding Strength of Multiple Donor Specific Antibodies Crossed at the Time of Heart Transplant Impact Post-Transplant Outcomes? Jon Kobashigawa, United States Does the Binding Strength of Multiple Donor Specific Antibodies Crossed at the Time of Heart Transplant Impact Post-Transplant Outcomes? Peter Chin, United States Long-Term Outcomes of Total Lymphoid Irradiation (TLI) Following Pediatric Heart Transplantation Peter Chin, United States Long-Term Outcomes of Total Lymphoid Irradiation (TLI) Following Pediatric Heart Transplantation Morgan Baughman, United States Evaluation of the Long-Term Outcomes of Hypomagnesemia Post Heart Transplantation Morgan Baughman, United States Evaluation of the Long-Term Outcomes of Hypomagnesemia Post Heart Transplantation
07:00-08:00	23	23 07:00 Rapid Fire Oral Abstract Session: Graft Under Pressure: Navigating BK Virus Full Details Ambreen Azhar, United States Molecular and Histological Insights into BK Virus-Associated Nephropathy in Kidney Transplant Recipients Ambreen Azhar, United States Molecular and Histological Insights into BK Virus-Associated Nephropathy in Kidney Transplant Recipients Ambreen Azhar, United States "Immune Predictors of BK Viremia Clearance: Role of BK Virus-Specific T-Cell Immunity in Kidney Transplant Recipients" Ambreen Azhar, United States "Immune Predictors of BK Viremia Clearance: Role of BK Virus-Specific T-Cell Immunity in Kidney Transplant Recipients" Elizabeth Hendren, Canada Changes in the Duration and Severity of BK Viral Load May as a Surrogate Outcome in Trials to Advance New Therapeutics for BK Virus Elizabeth Hendren, Canada Changes in the Duration and Severity of BK Viral Load May as a Surrogate Outcome in Trials to Advance New Therapeutics for BK Virus Matthew D'Costa, Singapore Intravenous Immunoglobulin as Adjunctive Treatment for BK DNAemia Matthew D'Costa, Singapore Intravenous Immunoglobulin as Adjunctive Treatment for BK DNAemia Hye Eun Kwon, Korea Comparative Analysis of Immunosuppressant Adjustments in BK Viremia Management: Sirolimus, Leflunomide, and MMF Tapering Hye Eun Kwon, Korea Comparative Analysis of Immunosuppressant Adjustments in BK Viremia Management: Sirolimus, Leflunomide, and MMF Tapering Alexis Piedrafita, France RNASeq Changes Associated with Polyomavirus-Associated Nephropathy: From Pathophysiology to Drug Repurposing Alexis Piedrafita, France RNASeq Changes Associated with Polyomavirus-Associated Nephropathy: From Pathophysiology to Drug Repurposing Hsu-Han Wang, Taiwan Adding on mTOR Inhibitors May Help Reducing Viral Load in BK Polyomavirus Infection After Kidney Transplantation Hsu-Han Wang, Taiwan Adding on mTOR Inhibitors May Help Reducing Viral Load in BK Polyomavirus Infection After Kidney Transplantation Nicole Clarke, United States The Risk Factors Developing BK Viraemia and Its Viral Kinetics in Kidney Transplant Recipients Nicole Clarke, United States The Risk Factors Developing BK Viraemia and Its Viral Kinetics in Kidney Transplant Recipients
07:00-08:00	153	153 07:00 Rapid Fire Oral Abstract Session: Deceased Donor Kidney Allocation Full Details John Montgomery, United States Obesity and Access to Out-of-Sequence Deceased Donor Kidney Transplantation John Montgomery, United States Obesity and Access to Out-of-Sequence Deceased Donor Kidney Transplantation Tainá Sandes-freitas, Brazil Pretransplant Virtual Epitope-Based Crossmatch is Associated with Worse Outcomes After Kidney Transplantation Tainá Sandes-freitas, Brazil Pretransplant Virtual Epitope-Based Crossmatch is Associated with Worse Outcomes After Kidney Transplantation Kenneth Andreoni, United States CPRA Sensitization Priority: The Need to Recalculate After Implementation of 250 nm Sharing Circles Kenneth Andreoni, United States CPRA Sensitization Priority: The Need to Recalculate After Implementation of 250 nm Sharing Circles Maria Kaisar, United Kingdom Plasma Uromodulin Dynamics in Deceased Donors: A Marker of Tubular Integrity for Post-Transplant Kidney Function Maria Kaisar, United Kingdom Plasma Uromodulin Dynamics in Deceased Donors: A Marker of Tubular Integrity for Post-Transplant Kidney Function Jennifer Philip, United States Hypothermic Machine Perfusion Parameters Are Associated with Donor Characteristics and Post-Transplant Outcomes in Deceased Donor Kidney Transplant Jennifer Philip, United States Hypothermic Machine Perfusion Parameters Are Associated with Donor Characteristics and Post-Transplant Outcomes in Deceased Donor Kidney Transplant Krista Lentine, United States A Pilot Randomized Trial of Approaches to Deceased Donor Kidney Procurement Biopsies: Operational Challenges and Lessons Learned Krista Lentine, United States A Pilot Randomized Trial of Approaches to Deceased Donor Kidney Procurement Biopsies: Operational Challenges and Lessons Learned Douglas Keith, United States Taking One for the Team, Should the Time Limit for Reinstatement of Waiting Time After Early Graft Loss Be Extended? Douglas Keith, United States Taking One for the Team, Should the Time Limit for Reinstatement of Waiting Time After Early Graft Loss Be Extended?
07:00-08:00	8	8 07:00 Rapid Fire Oral Abstract Session: Kidney: Cardiometabolic Issues Full Details Cayden Lawrence, United States Association of Right Ventricular Strain with Cardiovascular Outcomes in Kidney Transplant Recipients Cayden Lawrence, United States Association of Right Ventricular Strain with Cardiovascular Outcomes in Kidney Transplant Recipients Daniel Huck, United States Interplay of Inflammation, Dysregulated Angiogenesis, and Coronary Microvascular Dysfunction Among Patients Being Evaluated for Kidney Transplant Daniel Huck, United States Interplay of Inflammation, Dysregulated Angiogenesis, and Coronary Microvascular Dysfunction Among Patients Being Evaluated for Kidney Transplant Khang Nguyen, United States Pre-Transplant Revascularization Reduces Post-Kidney Transplant Major Adverse Cardiovascular Events Khang Nguyen, United States Pre-Transplant Revascularization Reduces Post-Kidney Transplant Major Adverse Cardiovascular Events Suwasin Udomkarnjananun, Thailand The Effect of Kidney Allograft Rejection on Post-Transplant Cardiovascular Complications Suwasin Udomkarnjananun, Thailand The Effect of Kidney Allograft Rejection on Post-Transplant Cardiovascular Complications Andrew Bentall, United States The Impact of Anticoagulation on Post-Transplant Complications - Impact on Deceased Donor Recipients Andrew Bentall, United States The Impact of Anticoagulation on Post-Transplant Complications - Impact on Deceased Donor Recipients Tatenda Mupfudze, United States The Impact of Obesity and Health Insurance on Kidney Transplantation and Waiting List Mortality Tatenda Mupfudze, United States The Impact of Obesity and Health Insurance on Kidney Transplantation and Waiting List Mortality Ophelia Yin, United States Preeclampsia in Kidney Transplant Recipients during Pregnancy and Its Impact on Graft Survival Ophelia Yin, United States Preeclampsia in Kidney Transplant Recipients during Pregnancy and Its Impact on Graft Survival Henry Zelada, United States Tolerability of Glucagon-Like Peptide 1 Receptor Agonists (GLP1-RA) in Kidney Transplant Recipients with Diabetes Henry Zelada, United States Tolerability of Glucagon-Like Peptide 1 Receptor Agonists (GLP1-RA) in Kidney Transplant Recipients with Diabetes
07:00-08:00	21	21 07:00 Late-Breaking Oral Abstract: Transplantation: Patient Access and Provider Perceptions Full Details Francisco J. Reyna Sepulveda, Mexico Recovery Without Equity: The Complex Post-COVID Landscape of Transplantation in Mexico Francisco J. Reyna Sepulveda, Mexico Recovery Without Equity: The Complex Post-COVID Landscape of Transplantation in Mexico Vivek Kute, India Analysis of Kidney and Liver Exchange Transplantation in India (2000-2025): A Multicentre, Retrospective Cohort Study Vivek Kute, India Analysis of Kidney and Liver Exchange Transplantation in India (2000-2025): A Multicentre, Retrospective Cohort Study Francisco J. Reyna Sepulveda, Mexico Strategic Insights into Organ Donation: Analyzing Perceptions, Attitudes, and Disincentive Removal Effects Francisco J. Reyna Sepulveda, Mexico Strategic Insights into Organ Donation: Analyzing Perceptions, Attitudes, and Disincentive Removal Effects Lijamol Joseph, United Arab Emirates Consent and Complexity: Organ Donation Decisions in a Multicultural UAE Organ Donation Program HAYAT Lijamol Joseph, United Arab Emirates Consent and Complexity: Organ Donation Decisions in a Multicultural UAE Organ Donation Program HAYAT Francisco J. Reyna Sepulveda, Mexico When Biology Meets Bureaucracy: Organ Waiting Times of Deceased Donor Organ Transplantation. 13 Years of Transplants in Mexico Francisco J. Reyna Sepulveda, Mexico When Biology Meets Bureaucracy: Organ Waiting Times of Deceased Donor Organ Transplantation. 13 Years of Transplants in Mexico Manpreet Samra, United States Transplant Professionals Perception Towards Age and Solid Organ Transplant: Survey Results Manpreet Samra, United States Transplant Professionals Perception Towards Age and Solid Organ Transplant: Survey Results
08:15 - 09:30 \| Parallel Symposia
08:15-09:30	10	10 08:15 Invited Symposia: An Update from TPAC (Transplant Pharmacy Adherence Consortium) on Transplant Adherence Sharing Published Experiences and Lessons Learned Full Details Ann Kataria, United States TRAMM Tool 2.0: Tips for Practice Utilization and EMR Integration Ann Kataria, United States TRAMM Tool 2.0: Tips for Practice Utilization and EMR Integration Krysta Walter, United States Share Strategies to Implement the Newly Developed Transplant Medication Adherence Videos Within Your Clinical Practice Krysta Walter, United States Share Strategies to Implement the Newly Developed Transplant Medication Adherence Videos Within Your Clinical Practice Tiffany Kaiser, United States Technology-Based Adherence Solutions Tiffany Kaiser, United States Technology-Based Adherence Solutions
08:15-09:30	22	22 08:15 Invited Symposia: Cell Therapy – Novel Approaches to Refine Immunosuppression and Immunity Full Details Leslie Kean, United States OX40l CAR-Directed Treg: Biology and Clinical Implications Leslie Kean, United States OX40l CAR-Directed Treg: Biology and Clinical Implications Nalan Utku, Germany Translating TIRC7 Expressing Treg to the Clinic Nalan Utku, Germany Translating TIRC7 Expressing Treg to the Clinic Angus Thomson, United States Using DC Regulatory Cells in Humans Angus Thomson, United States Using DC Regulatory Cells in Humans Susan Prockop, United States Adoptive Cell Therapy for Viral Infection in Transplant Recipients Susan Prockop, United States Adoptive Cell Therapy for Viral Infection in Transplant Recipients
08:15-09:30	154	154 08:15 Invited Symposia: Multi-drug-resistant Organisms: Challenging Cases Full Details Paolo Grossi, Italy Panelist Paolo Grossi, Italy Panelist Priscilla Rupali, India Panelist Priscilla Rupali, India Panelist Saima Aslam, United States Panelist Saima Aslam, United States Panelist Ghadeer Al-Ahmadi, Saudi Arabia Panelist Ghadeer Al-Ahmadi, Saudi Arabia Panelist
08:15-09:30	12	12 08:15 Invited Symposia: Multiorgan Transplantation in Pediatrics Full Details Armando Ganoza, United States Indications/Outcomes/Future Directions of Pediatric Multiorgan Transplant Armando Ganoza, United States Indications/Outcomes/Future Directions of Pediatric Multiorgan Transplant Swati Choudhry, United States Simultaneous Peds Heart/Kidney - When to Pull the Trigger Swati Choudhry, United States Simultaneous Peds Heart/Kidney - When to Pull the Trigger Lars Pape, Germany Combined Liver/Kidney Transplantation for Children Lars Pape, Germany Combined Liver/Kidney Transplantation for Children Anji Wall, United States Ethical Considerations for Multiorgan Transplantation in Children Anji Wall, United States Ethical Considerations for Multiorgan Transplantation in Children
08:15-09:30	11	11 08:15 Invited Symposia: International Selection Panel for Lung Transplant Full Details Jasleen Kukreja, United States Panelist Jasleen Kukreja, United States Panelist Robin Vos, Belgium Panelist Robin Vos, Belgium Panelist Marie Budev, United States Panelists Marie Budev, United States Panelists Konrad Hoetzenecker, United States Panelists Konrad Hoetzenecker, United States Panelists
08:15-09:30	153	153 08:15 Invited Symposia: The Global Perspective on Organ Donation Full Details Mohamed Rela, India Living Liver Donation Mohamed Rela, India Living Liver Donation Emily Vail, United States Donor Care Centers Emily Vail, United States Donor Care Centers Axel Rahmel, Germany Deceased Organ Donation Axel Rahmel, Germany Deceased Organ Donation Vivekanand Jha, India Living Kidney Donation Vivekanand Jha, India Living Kidney Donation
08:15-09:30	25	25 08:15 Invited Symposia: Clinical Trials: How Do We Promote Innovation? Full Details Amit Sharma, India Industry Perspective / Precision Medicine-Based Trials Amit Sharma, India Industry Perspective / Precision Medicine-Based Trials Roshan George, United States PROMs Roshan George, United States PROMs Michael Collins, Australia Faster Cheaper Better Trials Michael Collins, Australia Faster Cheaper Better Trials Laura Esserman, United States Innovative Trial Designs Laura Esserman, United States Innovative Trial Designs
08:15-09:30	21	21 08:15 Invited Symposia: Role of Robotics in Transplantation: Are We Ready for Prime Time? Full Details Dieter Broering, Saudi Arabia Advances in Robotic Liver Transplantation: The Recipient Dieter Broering, Saudi Arabia Advances in Robotic Liver Transplantation: The Recipient Jesse Davidson, United States Advances in Robotic Kidney Transplantation: The Donor Jesse Davidson, United States Advances in Robotic Kidney Transplantation: The Donor Pier Giulianotti, United States The Next Frontiers in Minimally Invasive Surgery for Transplantation Pier Giulianotti, United States The Next Frontiers in Minimally Invasive Surgery for Transplantation Yee Lee Cheah, United States Advances in Robotic Liver Transplantation: The Donor Yee Lee Cheah, United States Advances in Robotic Liver Transplantation: The Donor Phillipe Abreu, United States Advances in Robotic Kidney Transplantation: The Recipient Phillipe Abreu, United States Advances in Robotic Kidney Transplantation: The Recipient
08:15-09:30	20	20 08:15 Invited Symposia: Prehabilitation: A Proactive Approach to Improving Transplant Outcomes Full Details Jan Larmann, Germany Anesthetic Considerations to Optimize Post-transplant Recovery Jan Larmann, Germany Anesthetic Considerations to Optimize Post-transplant Recovery Christine Liu, United States Frailty in Kidney Transplant Recipients Christine Liu, United States Frailty in Kidney Transplant Recipients Babak Orandi, United States Perioperative Considerations in Older Recipients Babak Orandi, United States Perioperative Considerations in Older Recipients Tania Janaudis Ferreira, Canada Updates in Innovations in Prehabilitation for Solid Organ Transplant Recipients Tania Janaudis Ferreira, Canada Updates in Innovations in Prehabilitation for Solid Organ Transplant Recipients
08:15-09:30	155	155 08:15 Invited Symposia: Making It Easier: Removing Disincentives and Barriers from Live Donation Full Details Dempsey Hughes, United States Living Donor Protection Act Dempsey Hughes, United States Living Donor Protection Act Syed Husain, United States Financial Neutrality for Living Donors - NLDAC, LDCOE and Other Governmental Programs Syed Husain, United States Financial Neutrality for Living Donors - NLDAC, LDCOE and Other Governmental Programs Carrie Thiessen, United States Crowdfunding for Living Donors? Carrie Thiessen, United States Crowdfunding for Living Donors? Deirdre Sawinski, United States Improving the Efficiency of Living Donor Process Deirdre Sawinski, United States Improving the Efficiency of Living Donor Process
08:15-09:30	24	24 08:15 Invited Symposia: Manipulation of Organs During Machine Perfusion Full Details Seyed Alireza Rabi, United States Mending Broken Hearts: Organ Reconditioning for Transplantation Using siRNA-based Therapies During Ex Vivo Machine Perfusion Seyed Alireza Rabi, United States Mending Broken Hearts: Organ Reconditioning for Transplantation Using siRNA-based Therapies During Ex Vivo Machine Perfusion Sandra Lindstedt, Sweden Ex Vivo Lung Reconditioning: Xenotransplantation of Mitochondria Sandra Lindstedt, Sweden Ex Vivo Lung Reconditioning: Xenotransplantation of Mitochondria Rohit Gaurav, United Kingdom Opportunities to Optimize Livers During Perfusion: The Role of Sequential Perfusion Technology Rohit Gaurav, United Kingdom Opportunities to Optimize Livers During Perfusion: The Role of Sequential Perfusion Technology Leonie van Leeuwen, United States Ex Vivo Kidney Modulation: Opportunities for Drug Delivery and Organ Repair Leonie van Leeuwen, United States Ex Vivo Kidney Modulation: Opportunities for Drug Delivery and Organ Repair
08:15-09:30	8	8 08:15 Invited Symposia: Harnessing AI for Efficiency and Precision in Transplantation Full Details Mamatha Bhat, Canada AI: How It’s Going: Clinical Decision Making Mamatha Bhat, Canada AI: How It’s Going: Clinical Decision Making Allan Kirk, United States AI: Where It Could Lead Us Allan Kirk, United States AI: Where It Could Lead Us Antony Attia, United States AI: How it Started Antony Attia, United States AI: How it Started Leyla Warsame, United States AI: How It’s Going: Health Systems AI Governance Leyla Warsame, United States AI: How It’s Going: Health Systems AI Governance
08:15-09:30	9	9 08:15 Invited Symposia: Current Status of Hand and Face Transplantation Full Details L. Scott Levin, United States Hand Transplantation - Past, Present, and Future - Is It Time for Standard of Care? L. Scott Levin, United States Hand Transplantation - Past, Present, and Future - Is It Time for Standard of Care? Linda Cendales, United States The Role of NASEM in Validating Hand and Face Transplant in the USA Linda Cendales, United States The Role of NASEM in Validating Hand and Face Transplant in the USA Bruce Gelb, United States Unique Aspects of Immunosuppression in Face and Hand Transplant Bruce Gelb, United States Unique Aspects of Immunosuppression in Face and Hand Transplant Laurent Lantieri, France Face Transplantation - Past Present and Future Laurent Lantieri, France Face Transplantation - Past Present and Future
08:15-09:30	4	4 08:15 Invited Symposia: Innovations to Expand Living Kidney Donation Full Details Matt Cooper, United States Kidney Paired Donation Matt Cooper, United States Kidney Paired Donation Justin Gill, Canada Advanced Donation and Reciprocity-Based Strategies Justin Gill, Canada Advanced Donation and Reciprocity-Based Strategies Elisa Gordon, United States Elimination of Financial Disincentives / Incentives Elisa Gordon, United States Elimination of Financial Disincentives / Incentives Jim Rodrigue, United States From Stagnation to Transformation: A Multisystem Strategy for Growth Jim Rodrigue, United States From Stagnation to Transformation: A Multisystem Strategy for Growth
08:15-09:30	23	23 08:15 Invited Symposia: Transplant Oncology: Challenges and Innovation Full Details Naoka Murakami, United States Challenges and Innovation of Transplant Onconephrology Naoka Murakami, United States Challenges and Innovation of Transplant Onconephrology Anjana Pillai, United States Transplant Oncology - Liver: Challenges and Strategies to Advance the Field Anjana Pillai, United States Transplant Oncology - Liver: Challenges and Strategies to Advance the Field Ankit Bharat, United States Challenges and Opportunities in Thoracic Transplant Oncology Ankit Bharat, United States Challenges and Opportunities in Thoracic Transplant Oncology
10:00 - 12:45 \| Plenary Sessions
10:00-10:30	Plenary	Plenary 10:00 The Health Misinformation Crisis! - Timothy Caulfield Full Details Timothy Caulfield, Canada The Health Misinformation Crisis! Timothy Caulfield, Canada The Health Misinformation Crisis!
10:30-11:30	Plenary	Plenary 10:30 Plenary: Plenary Abstracts 1 Full Details Imad Aljabban, United States Longest Surviving Recipient of a Xenotransplant: Allo-Sensitized Patient Receiving a 10 Gene-Edited Pig  Kidney Imad Aljabban, United States Longest Surviving Recipient of a Xenotransplant: Allo-Sensitized Patient Receiving a 10 Gene-Edited Pig  Kidney David Taber, United States Burdens of Therapy: AST’s National Patient Survey of Unmet Immunosuppressant Needs David Taber, United States Burdens of Therapy: AST’s National Patient Survey of Unmet Immunosuppressant Needs Tao Luo, People's Republic of China Ischemia-Free Procedure Reshapes the Local and Systemic Immunity in Liver Transplantation Tao Luo, People's Republic of China Ischemia-Free Procedure Reshapes the Local and Systemic Immunity in Liver Transplantation Victor Ferreira, Canada Virus-Inclusive Single-Cell RNA Sequencing Reveals Broad Cellular Tropism and Common Pathway Dysfunctions Linked to Cytomegalovirus Infection in Organ Transplant Recipients Victor Ferreira, Canada Virus-Inclusive Single-Cell RNA Sequencing Reveals Broad Cellular Tropism and Common Pathway Dysfunctions Linked to Cytomegalovirus Infection in Organ Transplant Recipients
11:30-12:45	Plenary	Plenary 11:30 Presidential Addresses: AST Presidential Address & Society Awards Full Details AST WTC2025, United States Set Up Stage AST WTC2025, United States Set Up Stage David Foley, United States Presidents Address - Introduction David Foley, United States Presidents Address - Introduction Jon Kobashigawa, United States Presidential Speech Jon Kobashigawa, United States Presidential Speech Jon Kobashigawa, United States Lifetime Achievement Awards Jon Kobashigawa, United States Lifetime Achievement Awards David Foley, United States Grant Awards - Career Development Grants David Foley, United States Grant Awards - Career Development Grants David Foley, United States Grant Awards - Career Transition Awards David Foley, United States Grant Awards - Career Transition Awards David Foley, United States Grant Awards - Priority Grants David Foley, United States Grant Awards - Priority Grants David Foley, United States AJT Awards David Foley, United States AJT Awards Sandy Feng, United States AJT Awards Sandy Feng, United States AJT Awards AST WTC2025, United States Closing Announcements & Photos AST WTC2025, United States Closing Announcements & Photos
12:15 - 15:30 \| Parallel Symposia
12:15-15:30	12	12 12:15 Invited Symposia: Mechanisms of Antibody Mediated Rejection Full Details Emmanuel Zorn, United States Intra-Graft B Cell Populations After Heart Transplantation Emmanuel Zorn, United States Intra-Graft B Cell Populations After Heart Transplantation Peter Sage, United States Control of Antibody Mediated Rejection by CD4+ Follicular T Populations Peter Sage, United States Control of Antibody Mediated Rejection by CD4+ Follicular T Populations David Allman, United States Formation and Maintenance of Graft-Specific Plasma Cells David Allman, United States Formation and Maintenance of Graft-Specific Plasma Cells Christian Larsen, United States Identification of Epitopes Associated With Indirect Alloreactivity Christian Larsen, United States Identification of Epitopes Associated With Indirect Alloreactivity
12:15-15:30	10	10 12:15 Invited Symposia: Empowering Care Teams: Allied Health-Led Multidisciplinary Clinics for Transplant Patients Full Details Darnell Mompoint-Williams, United States Breaking Boundaries: APP-Led Specialty Clinic for ABO Incompatible and HIV-Positive Transplant Patients Darnell Mompoint-Williams, United States Breaking Boundaries: APP-Led Specialty Clinic for ABO Incompatible and HIV-Positive Transplant Patients Jillian Fose, United States Guardians of Immunity: Pharmacy-Led CMV Stewardship for Transplant Recipients Jillian Fose, United States Guardians of Immunity: Pharmacy-Led CMV Stewardship for Transplant Recipients Janice Kerr, United States Too Sweet: Pharmacy-Led Post-Transplant Diabetes Management Clinic Janice Kerr, United States Too Sweet: Pharmacy-Led Post-Transplant Diabetes Management Clinic Staci McKean, United States Decoding the Tower of Babel in Rejection: APP-Led Initiative in Complex Immunologic Cases Staci McKean, United States Decoding the Tower of Babel in Rejection: APP-Led Initiative in Complex Immunologic Cases
12:15-15:30	155	155 12:15 Invited Symposia: Heart Transplant Selection Criteria: Urban Legends, Myths, and Lies (Where's the Data?) Full Details Eileen Hsich, United States Panelist Eileen Hsich, United States Panelist Seyed Alireza Rabi, United States Panelist Seyed Alireza Rabi, United States Panelist Anne Dipchand, Canada Panelist Anne Dipchand, Canada Panelist Shelley Hall, United States Panelist Shelley Hall, United States Panelist Pedro Catarino, United States Panelist Pedro Catarino, United States Panelist
12:15-15:30	24	24 12:15 Invited Symposia: The ABCs of CMV Full Details Atul Humar, Canada CMV Prophylaxis vs Pre-emptive Therapy Atul Humar, Canada CMV Prophylaxis vs Pre-emptive Therapy Raymund Razonable, United States New Approaches for Treatment Raymund Razonable, United States New Approaches for Treatment Deepali Kumar, Canada Moving Forward with CMV Cell-mediated Immunity Deepali Kumar, Canada Moving Forward with CMV Cell-mediated Immunity Camille Kotton, United States Introduction to the New International Consensus Guidelines Camille Kotton, United States Introduction to the New International Consensus Guidelines
12:15-15:30	25	25 12:15 Invited Symposia: Update on OPTN in the United States Full Details Richard Formica, United States Don’t Throw the Baby Out with the Bathwater Richard Formica, United States Don’t Throw the Baby Out with the Bathwater Silke Niederhaus, United States Patient Perspectives from Within the Field Silke Niederhaus, United States Patient Perspectives from Within the Field Jeffrey Crippin, United States The History of the OPTN and its Accomplishments Jeffrey Crippin, United States The History of the OPTN and its Accomplishments Rexanah Morrissette, United States Previous Experience on OPTN Rexanah Morrissette, United States Previous Experience on OPTN
12:15-15:30	154	154 12:15 Invited Symposia: Nonutilization: How Do We Flip the Switch to Increase Utilization? Full Details Peter Reese, United States Is Non-use Mainly a US Problem? Peter Reese, United States Is Non-use Mainly a US Problem? Axel Rahmel, Germany Perspective on Utilization From Other Parts of the World Axel Rahmel, Germany Perspective on Utilization From Other Parts of the World Darren Stewart, United States Factors Contributing to Nonuse in the US Darren Stewart, United States Factors Contributing to Nonuse in the US
12:15-15:30	4	4 12:15 Invited Symposia: Non-invasive Biomarkers for Monitoring Kidney Transplant Recipients Full Details Enver Akalin, United States Comparison of Different Blood Transcriptomics for Rejection or Immune Quiescence Enver Akalin, United States Comparison of Different Blood Transcriptomics for Rejection or Immune Quiescence Jamil Azzi, United States Urinary Exosomes and Transcriptomics for Diagnosis of Rejection Jamil Azzi, United States Urinary Exosomes and Transcriptomics for Diagnosis of Rejection Alexandre Loupy, France The IBOX Prognostication System Alexandre Loupy, France The IBOX Prognostication System Klemens Budde, Germany Clinical Utility of Donor-Derived Cell-Free DNA Monitoring After Kidney Transplant Klemens Budde, Germany Clinical Utility of Donor-Derived Cell-Free DNA Monitoring After Kidney Transplant
12:15-15:30	23	23 12:15 Invited Symposia: Intestinal Transplantation Around the World: Updates and Perspectives Full Details Cal Matsumoto, United States North America Cal Matsumoto, United States North America Francisco Hernandez Oliverios, Spain Europe Francisco Hernandez Oliverios, Spain Europe Ehab Abufarhaneh, Saudi Arabia Middle East Ehab Abufarhaneh, Saudi Arabia Middle East Guosheng Wu, People's Republic of China Asia Guosheng Wu, People's Republic of China Asia Adam Testro, Australia Oceania Adam Testro, Australia Oceania Gabriel Gondolesi, United States South America Gabriel Gondolesi, United States South America
12:15-15:30	21	21 12:15 Invited Symposia: Working Beyond Borders: It Takes an International Village Full Details Stefano Bertozzi, United States The Pharmaceutical Industry’s Role in Expanding Global Health Initiatives Stefano Bertozzi, United States The Pharmaceutical Industry’s Role in Expanding Global Health Initiatives David Thomson, South Africa Developing Deceased Organ Donation in Africa David Thomson, South Africa Developing Deceased Organ Donation in Africa Jeffrey Punch, United States How Can Developed Countries Best Help Developing Countries? Jeffrey Punch, United States How Can Developed Countries Best Help Developing Countries? Vivekanand Jha, India Beyond Who: Enabling Global Capacity and Expertise Vivekanand Jha, India Beyond Who: Enabling Global Capacity and Expertise
12:15-15:15	11	11 12:15 Invited Symposia: Sex in Transplantation Full Details Friederike Martin, United States Impact of Hormones and Hormonal Receptors on Autoimmunity Friederike Martin, United States Impact of Hormones and Hormonal Receptors on Autoimmunity ANDREW MALONE, Ireland Loss of Y: Implications for Transplantation ANDREW MALONE, Ireland Loss of Y: Implications for Transplantation Shannon Dunn, Canada Sex Differences in Immune Responses Shannon Dunn, Canada Sex Differences in Immune Responses
12:15-15:15	20	20 12:15 Invited Symposia: Debrief of the First Annual DEI in Transplant Conference: Charting the Path Toward Equity in Transplantation Full Details Lisa McElroy, United States Gender, Racial, and Age Disparities Amongst Solid Organ Transplant Recipients Lisa McElroy, United States Gender, Racial, and Age Disparities Amongst Solid Organ Transplant Recipients Heather Badenoch, Canada Gift of Life: Navigating the Journey to Find a Live Donor Heather Badenoch, Canada Gift of Life: Navigating the Journey to Find a Live Donor Nigel Girgrah, United States Transforming Healthcare Systems to Support Transplant Professionals Nigel Girgrah, United States Transforming Healthcare Systems to Support Transplant Professionals
12:15-15:15	22	22 12:15 Invited Symposia: Mens Sana in Corpore Sano - The Underappreciated Issues of Mental Health in Transplant Full Details Paula Zimbrean, United States Incorporating Tools to Assess Mental Health and Cognitive Function in the Transplant Evaluation Paula Zimbrean, United States Incorporating Tools to Assess Mental Health and Cognitive Function in the Transplant Evaluation Makayla Cordoza, United States Assessing and Managing Post-transplant Delirium Makayla Cordoza, United States Assessing and Managing Post-transplant Delirium Ken Lotherington, Canada Caregiver Fatigue and Burnout Ken Lotherington, Canada Caregiver Fatigue and Burnout
12:15-15:30	8	8 12:15 Invited Symposia: How to Optimise a More Global Research Infrastructure Redefining the Clinical and Scientific Landscape in the Era of AI Full Details Maria Kaisar, United Kingdom Fingerprinting the Donor and Organ Quality Predicting Post Transplant Outcomes Maria Kaisar, United Kingdom Fingerprinting the Donor and Organ Quality Predicting Post Transplant Outcomes Brendan Keating, United States Genetic and Other Recipient Factors Impacting Success in Transplantation Brendan Keating, United States Genetic and Other Recipient Factors Impacting Success in Transplantation Maria Kaisar, United Kingdom Panelist Plus 1 Minute Vision Statement: Platform Development and Collaboration (QUOD Perspective) Maria Kaisar, United Kingdom Panelist Plus 1 Minute Vision Statement: Platform Development and Collaboration (QUOD Perspective) Brendan Keating, United States Panelist Plus 1 Minute Vision Statement: Integrated Bioresources and AI - iGeneTRAIN Perspective Brendan Keating, United States Panelist Plus 1 Minute Vision Statement: Integrated Bioresources and AI - iGeneTRAIN Perspective Chris Jaynes, United States Panelist Plus 1 Minute Vision Statement: Integrated Bioresources and AI - KIT-GENIE Perspective Chris Jaynes, United States Panelist Plus 1 Minute Vision Statement: Integrated Bioresources and AI - KIT-GENIE Perspective Anthony Langone, United States Panelist Plus 1 Minute Vision Statement: Role and Vision of NIH of Integrated Bioresources and AI Anthony Langone, United States Panelist Plus 1 Minute Vision Statement: Role and Vision of NIH of Integrated Bioresources and AI Antonio Gomes, Netherlands A Robust Snapshot of Relevant Donor and Recipients Factors in Kidney Transplantation Antonio Gomes, Netherlands A Robust Snapshot of Relevant Donor and Recipients Factors in Kidney Transplantation
12:15-15:30	9	9 12:15 Late-Breaking Oral Abstract: Liver Transplantation and Machine Perfusion Full Details Michelle Nguyen, United States Normothermic Machine Perfusion Equalizes Graft Survival in DCD and DBD Liver Transplantation Michelle Nguyen, United States Normothermic Machine Perfusion Equalizes Graft Survival in DCD and DBD Liver Transplantation Khaled Ali, United States Are the Flows Sufficient? Potential of Oxygen Extraction Ratio during Normothermic Machine Perfusion of Human Liver Grafts as a Marker of Perfusion Quality. Khaled Ali, United States Are the Flows Sufficient? Potential of Oxygen Extraction Ratio during Normothermic Machine Perfusion of Human Liver Grafts as a Marker of Perfusion Quality. Michelle Nguyen, United States Low Bile Output During Normothermic Machine Perfusion Is Not Predictive of Poor Graft Outcomes Michelle Nguyen, United States Low Bile Output During Normothermic Machine Perfusion Is Not Predictive of Poor Graft Outcomes Valberto Sanha, United States The Impact of Routine Application of Normothermic Machine Perfusion in Liver Transplantation: Making the Unacceptable Acceptable Valberto Sanha, United States The Impact of Routine Application of Normothermic Machine Perfusion in Liver Transplantation: Making the Unacceptable Acceptable Dharesh Raj Amarnath, United Kingdom Donor Time to Death and DCD Liver Transplant Outcomes: Challenging the Dogma that Shorter is Better Dharesh Raj Amarnath, United Kingdom Donor Time to Death and DCD Liver Transplant Outcomes: Challenging the Dogma that Shorter is Better Alissa Cutrone, United States Normothermic Machine Perfusion of Moderately Steatotic Livers Alissa Cutrone, United States Normothermic Machine Perfusion of Moderately Steatotic Livers Geofia Crasta, United States Novel Approach to Viability Assessment of Split Liver Grafts Using Hypothermic Oxygenated Perfusion Geofia Crasta, United States Novel Approach to Viability Assessment of Split Liver Grafts Using Hypothermic Oxygenated Perfusion Marco Maria Pascale, Italy Clinical and Logistical Impact of Machine Perfusion in a Low Volume Liver Transplant Center Marco Maria Pascale, Italy Clinical and Logistical Impact of Machine Perfusion in a Low Volume Liver Transplant Center
16:30 - 17:45 \| Abstract Sessions
16:30-17:45	9	9 16:30 Oral Abstract: Next-Gen Biomarkers Full Details Kevin Louis, France Innate-Like CD8 T Cell Response to Kidney Graft: A Multimodal Profiling Study of Transplant Rejection Kevin Louis, France Innate-Like CD8 T Cell Response to Kidney Graft: A Multimodal Profiling Study of Transplant Rejection Philip Halloran, Canada Cellular Deconvolution of Microarray Data from Transplant Biopsies Predicts a Central Role for CD3/CD28 Stimulated CD4 Memory T Cells in Human T Cell-Mediated Rejection in All Organ Transplants Philip Halloran, Canada Cellular Deconvolution of Microarray Data from Transplant Biopsies Predicts a Central Role for CD3/CD28 Stimulated CD4 Memory T Cells in Human T Cell-Mediated Rejection in All Organ Transplants Raphaela Bento, United States Early Reporting of Transplant Rejection: Genetically Engineered ‘Smart-Organs’ Featuring Diagnostic Capabilities Raphaela Bento, United States Early Reporting of Transplant Rejection: Genetically Engineered ‘Smart-Organs’ Featuring Diagnostic Capabilities Avery Fortier, United States Metabolomic Signatures of Perfused Livers Reveal Early Evaluation May Be Superior Avery Fortier, United States Metabolomic Signatures of Perfused Livers Reveal Early Evaluation May Be Superior Evgenia Preka, France Urinary and Blood mRNA Biomarkers for Detecting Kidney Allograft Rejection (The KTD-Innov Study: NCT03582436) Evgenia Preka, France Urinary and Blood mRNA Biomarkers for Detecting Kidney Allograft Rejection (The KTD-Innov Study: NCT03582436) Sarah Tsou, United States Immune-Metabolism in Acute Heart Transplant Rejection: A Metabolomics Approach to Biomarker Identification in Mice Sarah Tsou, United States Immune-Metabolism in Acute Heart Transplant Rejection: A Metabolomics Approach to Biomarker Identification in Mice Alexander Kroemer, United States Circulating, Cell-Free Methylated DNA Indicates Cellular Sources of Allograft Injury After Liver Transplant Alexander Kroemer, United States Circulating, Cell-Free Methylated DNA Indicates Cellular Sources of Allograft Injury After Liver Transplant
16:30-17:45	24	24 16:30 Oral Abstract: Xenotransplantation: Pushing Boundaries Full Details Qian Guo, United States Longitudinal Multi-Omics Profiling Reveals Molecular Responses in a Living Human Receiving a Gene-Edited Pig Kidney Xenograft Qian Guo, United States Longitudinal Multi-Omics Profiling Reveals Molecular Responses in a Living Human Receiving a Gene-Edited Pig Kidney Xenograft Kiana Moi, United States Comprehensive Long-Read Whole Genome Sequencing in 7 Human Xenotransplant Recipients Kiana Moi, United States Comprehensive Long-Read Whole Genome Sequencing in 7 Human Xenotransplant Recipients M. Esad Gunes, United States GLP Preclinical Trial of Pig-to-Baboon Thymokidney Xenotransplantation Using Inbred GalT-KO Miniature Swine Donors M. Esad Gunes, United States GLP Preclinical Trial of Pig-to-Baboon Thymokidney Xenotransplantation Using Inbred GalT-KO Miniature Swine Donors Bryar Hansen, United States Blockade of CD40 with or without CD11b versus CD154 Blockade in GTKO and hCD55 Transgenic Pig-to-Macaque Kidney Xenotransplantation Bryar Hansen, United States Blockade of CD40 with or without CD11b versus CD154 Blockade in GTKO and hCD55 Transgenic Pig-to-Macaque Kidney Xenotransplantation Valentin Goutaudier, France Spatial Multimodal Characterization of Long-Term Immune Response After Pig-to-Human Kidney Xenotransplantation Valentin Goutaudier, France Spatial Multimodal Characterization of Long-Term Immune Response After Pig-to-Human Kidney Xenotransplantation Mercy Rophina, United States Urinary Single-Cell RNA Sequencing from a Pig Kidney to Living Human Xenotransplantation Reveals Dynamic Cellular Changes Mercy Rophina, United States Urinary Single-Cell RNA Sequencing from a Pig Kidney to Living Human Xenotransplantation Reveals Dynamic Cellular Changes SHU LI, United States Incompatibility of Porcine Endothelial Cell-Derived Extracellular Vesicles and Human Endothelial Cells SHU LI, United States Incompatibility of Porcine Endothelial Cell-Derived Extracellular Vesicles and Human Endothelial Cells Ivy Rosales, United States Systemic Transfer of Endothelial Molecules of Recipient Origin to Pig Kidney Xenograft Endothelium Ivy Rosales, United States Systemic Transfer of Endothelial Molecules of Recipient Origin to Pig Kidney Xenograft Endothelium
16:30-17:45	4	4 16:30 Oral Abstract: Cytomegalovirus: Antivirals and Immune Defense Full Details David Taber, United States 6-Month Outcomes of a Randomized Controlled Trial Comparing the Tolerability and Efficacy of Maribavir vs. Valganciclovir for CMV Prophylaxis in High-Risk Kidney Transplant Recipients David Taber, United States 6-Month Outcomes of a Randomized Controlled Trial Comparing the Tolerability and Efficacy of Maribavir vs. Valganciclovir for CMV Prophylaxis in High-Risk Kidney Transplant Recipients IRFAN MOINUDDIN, United States CMV T-Cell Immunity Assay Based Guidance to Interrupt Prophylaxis in Intermediate Risk Kidney Transplant Patients IRFAN MOINUDDIN, United States CMV T-Cell Immunity Assay Based Guidance to Interrupt Prophylaxis in Intermediate Risk Kidney Transplant Patients Kennedy Concannon, United States Low-Dose Valganciclovir for Primary Cytomegalovirus Prophylaxis After Heart Transplant Kennedy Concannon, United States Low-Dose Valganciclovir for Primary Cytomegalovirus Prophylaxis After Heart Transplant Chelsea Morinishi, United States Risk Factors and Real-World Implications of CMV Resistance Mutations After Treatment with Maribavir or Foscarnet for Resistant and Refractory CMV Chelsea Morinishi, United States Risk Factors and Real-World Implications of CMV Resistance Mutations After Treatment with Maribavir or Foscarnet for Resistant and Refractory CMV Franco Citterio, Italy Prevention of CMV and BKV in De Novo Kidney Transplant Recipients Immunosuppressed with the Combination of Low Dose Tacrolimus and Everolimus Franco Citterio, Italy Prevention of CMV and BKV in De Novo Kidney Transplant Recipients Immunosuppressed with the Combination of Low Dose Tacrolimus and Everolimus Zachary Yetmar, United States Effect of Secondary Prophylaxis on the Risk of Recurrent Cytomegalovirus Infection Among Solid Organ Transplant Recipients Zachary Yetmar, United States Effect of Secondary Prophylaxis on the Risk of Recurrent Cytomegalovirus Infection Among Solid Organ Transplant Recipients Bongha Shin, United States Impaired CMV-Specific CD8⁺ T Cell Responses Correlate with Increased CMV Viremia in Kidney Transplant Recipients: A Comparative Analysis of Adult and Pediatric Patients Bongha Shin, United States Impaired CMV-Specific CD8⁺ T Cell Responses Correlate with Increased CMV Viremia in Kidney Transplant Recipients: A Comparative Analysis of Adult and Pediatric Patients Harry Pickering, United Kingdom Pre-Viremic, Multi-Omic Immune Signatures of Cytomegalovirus Infection in Kidney Transplant Recipients Harry Pickering, United Kingdom Pre-Viremic, Multi-Omic Immune Signatures of Cytomegalovirus Infection in Kidney Transplant Recipients
16:30-17:45	22	22 16:30 Oral Abstract: New Frontiers in Lung Transplantation Full Details Jianing Fu, United States Immunogenomic Landscape of T Cell Repertoires After Human Lung Transplantation and Its Clinical Significance Jianing Fu, United States Immunogenomic Landscape of T Cell Repertoires After Human Lung Transplantation and Its Clinical Significance Sho Takemoto, United States Lung Xenotransplantation Outcomes Using Multi-Gene Edited Pigs: In Vivo Transplant and Ex Vivo Human Xenoperfusion Sho Takemoto, United States Lung Xenotransplantation Outcomes Using Multi-Gene Edited Pigs: In Vivo Transplant and Ex Vivo Human Xenoperfusion Rashmi Prava Mohanty, United States T-Cell Receptor Repertoire Diversity and Change are Associated with Response to Extracorporeal Photopheresis for Chronic Lung Allograft Dysfunction Rashmi Prava Mohanty, United States T-Cell Receptor Repertoire Diversity and Change are Associated with Response to Extracorporeal Photopheresis for Chronic Lung Allograft Dysfunction Philip Halloran, Canada Molecular Diagnosis of Rejection in Lung Transplant Mucosal Biopsies Philip Halloran, Canada Molecular Diagnosis of Rejection in Lung Transplant Mucosal Biopsies Allen Duong, Canada In Vitro Characterization of Pro-Inflammatory LILRB2+ and Pro-Fibrotic SPP1+ Pulmonary Macrophages in Chronic Lung Allograft Dysfunction Allen Duong, Canada In Vitro Characterization of Pro-Inflammatory LILRB2+ and Pro-Fibrotic SPP1+ Pulmonary Macrophages in Chronic Lung Allograft Dysfunction Marta Sablik, France Banff Human Organ Transplant Panel for Detecting Acute Cellular Rejection in Lung Transplant Biopsies Marta Sablik, France Banff Human Organ Transplant Panel for Detecting Acute Cellular Rejection in Lung Transplant Biopsies Bhavya Kapse, United States Airway Epithelial P53 Expression is a Molecular Driver of Chronic Lung Allograft Dysfunction Bhavya Kapse, United States Airway Epithelial P53 Expression is a Molecular Driver of Chronic Lung Allograft Dysfunction Philip Halloran, Canada Trifecta-Lung Study: dd-cfDNA Correlates with T Cell-Mediated Rejection and Parenchymal Injury in Mucosal Biopsies of Lung Transplants Philip Halloran, Canada Trifecta-Lung Study: dd-cfDNA Correlates with T Cell-Mediated Rejection and Parenchymal Injury in Mucosal Biopsies of Lung Transplants
16:30-17:45	20	20 16:30 Oral Abstract: The Current Heart Allocation System: Wins and Losses Full Details Alyssa Mezochow, United States Illness Severity Among Heart Transplant Recipients Following 2018 Allocation Change Alyssa Mezochow, United States Illness Severity Among Heart Transplant Recipients Following 2018 Allocation Change Amit Alam, United States Short and Long Term Outcomes Across All Three Heart Transplant Allocation Eras Amit Alam, United States Short and Long Term Outcomes Across All Three Heart Transplant Allocation Eras Najiya Fatma, United States Waitlist Mortality Risk (US-CRS Score) Distribution Among Status 1 and 2 Adult Heart Transplant Candidates with Exceptions Najiya Fatma, United States Waitlist Mortality Risk (US-CRS Score) Distribution Among Status 1 and 2 Adult Heart Transplant Candidates with Exceptions Stratton Tolmie, United States Practice Changes at Transplant Centers 5 Years After 2018 US Heart Allocation Policy Change Stratton Tolmie, United States Practice Changes at Transplant Centers 5 Years After 2018 US Heart Allocation Policy Change Daniel Ahn, United States Low Rates of Dischargeable Left Ventricular Assist Device Placement Following Temporary Non-Surgical Mechanical Circulatory Support Among Status 2 Heart Transplant Candidates Daniel Ahn, United States Low Rates of Dischargeable Left Ventricular Assist Device Placement Following Temporary Non-Surgical Mechanical Circulatory Support Among Status 2 Heart Transplant Candidates Alina Martinez, United States Analysis of Time Waiting by Adult Heart Candidates Listed with an LVAD Alina Martinez, United States Analysis of Time Waiting by Adult Heart Candidates Listed with an LVAD Joshua Chan, United States Early versus Late Postoperative Renal Replacement Therapy and Associated Outcomes Following Combined Heart-Kidney Transplantation: A UNOS National Database Analysis Joshua Chan, United States Early versus Late Postoperative Renal Replacement Therapy and Associated Outcomes Following Combined Heart-Kidney Transplantation: A UNOS National Database Analysis Dhirisha Bhatt, United States Mortality and Acute Renal Failure Following Simultaneous Heart-Kidney Transplantation (SHK) vs. Heart Transplant Alone (HAT) in Recipients with Moderate to Severe Renal Dysfunction in the United States Dhirisha Bhatt, United States Mortality and Acute Renal Failure Following Simultaneous Heart-Kidney Transplantation (SHK) vs. Heart Transplant Alone (HAT) in Recipients with Moderate to Severe Renal Dysfunction in the United States
16:30-17:45	8	8 16:30 Oral Abstract: Organ Donation Full Details Joaquim Albiol, Spain Asymmetric Parallelism - The Positive Impact of Transplant Procurement Management Training Programs on Deceased Donation Activity Worldwide Joaquim Albiol, Spain Asymmetric Parallelism - The Positive Impact of Transplant Procurement Management Training Programs on Deceased Donation Activity Worldwide Vijay Subramanian, United States Why Fly When You Can Drive! - Utilizing Controlled Hypothermic Preservation to Facilitate Long Distance Ground Transportation Vijay Subramanian, United States Why Fly When You Can Drive! - Utilizing Controlled Hypothermic Preservation to Facilitate Long Distance Ground Transportation Molly White, United States A Novel Comprehensive Assessment of Transplant Center Offer Acceptance Practices Molly White, United States A Novel Comprehensive Assessment of Transplant Center Offer Acceptance Practices Ernesto Duarte Tagles, Mexico Exploring New Ways to Increase Organ Donation Rate, the First Museum of Donation and Transplantation in the World Ernesto Duarte Tagles, Mexico Exploring New Ways to Increase Organ Donation Rate, the First Museum of Donation and Transplantation in the World Kate Rokoss, Canada Effectively Engaging High School Students About Organ Donation and Transplantation: An Updated on the High School Outreach Initiative Experience Kate Rokoss, Canada Effectively Engaging High School Students About Organ Donation and Transplantation: An Updated on the High School Outreach Initiative Experience Sharan Alexander, United Arab Emirates Cross-Border Organ Donation and Transplantation: The UAE Experience in Regional Collaboration with Saudi Arabia and Kuwait Sharan Alexander, United Arab Emirates Cross-Border Organ Donation and Transplantation: The UAE Experience in Regional Collaboration with Saudi Arabia and Kuwait Mustafa Nazzal, United States The Impact of a Merit Point Incentive System on the Willingness to Donate Among Non-Registered Individuals Mustafa Nazzal, United States The Impact of a Merit Point Incentive System on the Willingness to Donate Among Non-Registered Individuals Marissa Di Napoli, United States From Clicks to Compassion: Social Media Use Significantly Drives Altruistic Living Organ Donations in Liver and Kidney Transplantation Marissa Di Napoli, United States From Clicks to Compassion: Social Media Use Significantly Drives Altruistic Living Organ Donations in Liver and Kidney Transplantation
16:30-17:45	23	23 16:30 Oral Abstract: Psychosocial Full Details Krista Lentine, United States Associations of Marijuana Use History with Progression from Living Donor Candidate Evaluation to Approval: Analysis of the US SRTR Living Donor Collective Krista Lentine, United States Associations of Marijuana Use History with Progression from Living Donor Candidate Evaluation to Approval: Analysis of the US SRTR Living Donor Collective Natalia Rodriguez-Payan, Mexico Identifying Risk Factors for Return to Alcohol Use After Liver Transplant Natalia Rodriguez-Payan, Mexico Identifying Risk Factors for Return to Alcohol Use After Liver Transplant Sarah Hussain, United States PROMETHEUS: Patient Reported Ethics Outcomes Following Transplants from Donors with or without HIV Sarah Hussain, United States PROMETHEUS: Patient Reported Ethics Outcomes Following Transplants from Donors with or without HIV Nicolas Muñoz, United States Financial Burden and Social Needs in Solid Organ Transplant Candidates Nicolas Muñoz, United States Financial Burden and Social Needs in Solid Organ Transplant Candidates Istvan Mucsi, Canada Health-Related Quality of Life in Kidney Transplant Recipients: Association with Graft Function and Comparison to Patients on Dialysis Istvan Mucsi, Canada Health-Related Quality of Life in Kidney Transplant Recipients: Association with Graft Function and Comparison to Patients on Dialysis José Pestana, Brazil Validation of the Modified Transplant Symptom Occurrence and Symptom Distress Scale (MTSOSD-59R) in Brazilian Kidney Transplant Recipients José Pestana, Brazil Validation of the Modified Transplant Symptom Occurrence and Symptom Distress Scale (MTSOSD-59R) in Brazilian Kidney Transplant Recipients Jesse Schold, United States Out of Pocket (OOP) Medical Costs for Transplant Recipients Before and After Transplantation Jesse Schold, United States Out of Pocket (OOP) Medical Costs for Transplant Recipients Before and After Transplantation Jingyao Hong, United States Cognitive Function Impacts Waitlist Mortality Risk for Some but Not All Solid Organ Candidates Jingyao Hong, United States Cognitive Function Impacts Waitlist Mortality Risk for Some but Not All Solid Organ Candidates
16:30-17:45	153	153 16:30 Oral Abstract: Post Liver Transplant Complications Full Details Vadim Jucaud, United States Vascularized Liver Tissueoid-on-a-Chip: An In Vitro Model for Studying Allograft Rejection Vadim Jucaud, United States Vascularized Liver Tissueoid-on-a-Chip: An In Vitro Model for Studying Allograft Rejection Zeynep DEMIR, France Molecular Signatures of Rejection in Liver Transplant Biopsies Using the Banff Human Organ Transplant Consensus Gene Panel Zeynep DEMIR, France Molecular Signatures of Rejection in Liver Transplant Biopsies Using the Banff Human Organ Transplant Consensus Gene Panel Rakesh Sindhi, United States Single-Cell and Spatial Genomics Reveal T-Cell Priming, Spatially Differentiated Networks and Novel Drug Targets in Early T-Cell-Mediated Liver Transplant (TCMR, LT) Rejection Rakesh Sindhi, United States Single-Cell and Spatial Genomics Reveal T-Cell Priming, Spatially Differentiated Networks and Novel Drug Targets in Early T-Cell-Mediated Liver Transplant (TCMR, LT) Rejection Min Kyoung Kim, Korea Clinical Impact of Desensitization in HLA-Incompatible Liver Transplantation: A Propensity Score-Matched Multicenter Analysis Min Kyoung Kim, Korea Clinical Impact of Desensitization in HLA-Incompatible Liver Transplantation: A Propensity Score-Matched Multicenter Analysis Adnan Sharif, United Kingdom Major Adverse Cardiovascular Events After Liver Transplantation: An English Population Cohort Analysis Adnan Sharif, United Kingdom Major Adverse Cardiovascular Events After Liver Transplantation: An English Population Cohort Analysis Richard Mangus, United States Impact of Pre-Liver Transplant Hepatic Encephalopathy and Post-Liver Transplant Altered Mental Status on Post-Transplant Outcomes Richard Mangus, United States Impact of Pre-Liver Transplant Hepatic Encephalopathy and Post-Liver Transplant Altered Mental Status on Post-Transplant Outcomes Yuqi Dong, People's Republic of China Ischemia-Free Liver Transplantation Alleviates Post-Transplant Myocardial Injury and Pulmonary Complication: A Post Hoc Analysis from IFLT-DBD Trial Yuqi Dong, People's Republic of China Ischemia-Free Liver Transplantation Alleviates Post-Transplant Myocardial Injury and Pulmonary Complication: A Post Hoc Analysis from IFLT-DBD Trial Brooke Rice, United States Preventing Alcohol Relapse in High-Risk Liver Transplant Recipients: Evaluation of a Multi-Disciplinary Post-Transplant Clinic Brooke Rice, United States Preventing Alcohol Relapse in High-Risk Liver Transplant Recipients: Evaluation of a Multi-Disciplinary Post-Transplant Clinic
16:30-17:45	21	21 16:30 Oral Abstract: Recurrent Disease and Genetics Full Details Andrew Bomback, United States Pegcetacoplan for Posttransplant Patients with Complement 3 Glomerulopathy or Primary (Idiopathic) Immune-Complex Membranoproliferative Glomerulonephritis Andrew Bomback, United States Pegcetacoplan for Posttransplant Patients with Complement 3 Glomerulopathy or Primary (Idiopathic) Immune-Complex Membranoproliferative Glomerulonephritis Moreno Rodrigues, United States Impact of APOL1 Risk Alleles on HIV+ to HIV+ Kidney Transplant Outcomes in South Africa and the United States Moreno Rodrigues, United States Impact of APOL1 Risk Alleles on HIV+ to HIV+ Kidney Transplant Outcomes in South Africa and the United States Parthenopi Avaniadi, Germany Daratumumab in Recurrent FSGS After Kidney Transplantation Parthenopi Avaniadi, Germany Daratumumab in Recurrent FSGS After Kidney Transplantation Marie-Camille Lafargue, United States Development of a Novel Mouse Model of Focal Segmental Glomerulosclerosis Recurrence Post-Kidney Transplantation Mediated by Anti-Nephrin Antibodies Marie-Camille Lafargue, United States Development of a Novel Mouse Model of Focal Segmental Glomerulosclerosis Recurrence Post-Kidney Transplantation Mediated by Anti-Nephrin Antibodies Francesca Zanoni, Italy Polygenic Risk Score Predicts IgA Nephropathy Recurrence and Graft Failure in Kidney Transplant Recipients Francesca Zanoni, Italy Polygenic Risk Score Predicts IgA Nephropathy Recurrence and Graft Failure in Kidney Transplant Recipients Frank Hullekes, United States Recurrence of C3GN and DDD After Kidney Transplantation: TANGO Consortium Frank Hullekes, United States Recurrence of C3GN and DDD After Kidney Transplantation: TANGO Consortium Francesca Zanoni, Italy Genetic Determinants of Kidney Transplant Outcomes: A Large-Scale Multi-Ancestry GWAS Meta-Analysis Francesca Zanoni, Italy Genetic Determinants of Kidney Transplant Outcomes: A Large-Scale Multi-Ancestry GWAS Meta-Analysis Yasar Caliskan, United States LIMS1 rs893403-GG Genotype and Its Impact on Recurrent/De Novo Glomerulonephritis in Kidney Transplant Recipients Yasar Caliskan, United States LIMS1 rs893403-GG Genotype and Its Impact on Recurrent/De Novo Glomerulonephritis in Kidney Transplant Recipients
16:30-17:45	25	25 16:30 Oral Abstract: Deceased Donor Selection/Utilization Full Details Douglas Keith, United States Changes in Donor Quality and Discards over Time: Analysis of Kidney Procurement and Transplantation over the Last 20 Years in the United States Douglas Keith, United States Changes in Donor Quality and Discards over Time: Analysis of Kidney Procurement and Transplantation over the Last 20 Years in the United States Philip Halloran, Canada Older Donor Age in Transplanted Kidneys Adversely Impacts the Response to Injury, Increasing Failed Repair Philip Halloran, Canada Older Donor Age in Transplanted Kidneys Adversely Impacts the Response to Injury, Increasing Failed Repair Ondrej Viklicky, Czech Republic Archetypal Analysis of Deceased Donor Kidneys: A Molecular Approach for Posttransplant Outcomes Ondrej Viklicky, Czech Republic Archetypal Analysis of Deceased Donor Kidneys: A Molecular Approach for Posttransplant Outcomes Philip Halloran, Canada Molecular Injury in Deceased-Donor Kidneys at Kidney Removal is Associated with Donor Age, KDPI and with Future Kidney Function (Serum Creatinine) Philip Halloran, Canada Molecular Injury in Deceased-Donor Kidneys at Kidney Removal is Associated with Donor Age, KDPI and with Future Kidney Function (Serum Creatinine) Hemant Sharma, United Kingdom Predictors of Kidney Graft Outcomes in Transplants from Acute Kidney Injury Donors - AKI Donor Graft Outcomes Study (ADOPT) Hemant Sharma, United Kingdom Predictors of Kidney Graft Outcomes in Transplants from Acute Kidney Injury Donors - AKI Donor Graft Outcomes Study (ADOPT) Thomas Dolan, United States Defining Hard-to-Place Kidney Donors Thomas Dolan, United States Defining Hard-to-Place Kidney Donors Hatem Ali, United Kingdom Equitable Donor Assessment Model (EDAM): A Data-Driven Framework for Stratifying Deceased Donor Kidney Quality Hatem Ali, United Kingdom Equitable Donor Assessment Model (EDAM): A Data-Driven Framework for Stratifying Deceased Donor Kidney Quality Jimena Alaniz, United States The Impact of Pre-Transplant Biopsy on Kidney Graft Selection: A Comparative Study in High KDPI Patients Jimena Alaniz, United States The Impact of Pre-Transplant Biopsy on Kidney Graft Selection: A Comparative Study in High KDPI Patients
16:30-17:45	154	154 16:30 Oral Abstract: Kidney: Hot Topics Full Details Teresa Po-Yu Chiang, United States Stop Calling Us!: Preemptive Identification of Kidneys with Virtually Zero Chance of Acceptance Teresa Po-Yu Chiang, United States Stop Calling Us!: Preemptive Identification of Kidneys with Virtually Zero Chance of Acceptance Reza Saidi, United States Evaluating Outcomes of Preemptive Kidney Transplant in Patients over 65 Using High-KDPI Kidneys Compared to Non-Preemptive Recipients Reza Saidi, United States Evaluating Outcomes of Preemptive Kidney Transplant in Patients over 65 Using High-KDPI Kidneys Compared to Non-Preemptive Recipients Marcelo Cantarovich, Canada Global Survey on Access to Transplantation: Knowledge and Comfort Gaps in the Acceptance of Kidneys from Deceased Donors Marcelo Cantarovich, Canada Global Survey on Access to Transplantation: Knowledge and Comfort Gaps in the Acceptance of Kidneys from Deceased Donors Abraham Matar, United States Eplet Matching Using a Novel Imputational Algorithm Predicts Long-Term Outcomes in Deceased Donor Kidney Transplantation Abraham Matar, United States Eplet Matching Using a Novel Imputational Algorithm Predicts Long-Term Outcomes in Deceased Donor Kidney Transplantation Lauren Matevish, United States Delayed Graft Function After Kidney Transplant: Unwanted Complication or Metric of Center Excellence? Lauren Matevish, United States Delayed Graft Function After Kidney Transplant: Unwanted Complication or Metric of Center Excellence? David Cron, United States Association Between Out of Sequence Allocation and Deceased Donor Kidney Non-Utilization Across Organ Procurement Organizations David Cron, United States Association Between Out of Sequence Allocation and Deceased Donor Kidney Non-Utilization Across Organ Procurement Organizations Elizabeth O'Day, United States Development and Validation of a Non-Invasive Urinary Metabolite Signature to Differentiate Stable Graft from Graft Injury in Large Scale Multi-Center Study Elizabeth O'Day, United States Development and Validation of a Non-Invasive Urinary Metabolite Signature to Differentiate Stable Graft from Graft Injury in Large Scale Multi-Center Study Joshua Kettelkamp, United States Performance of Computable Phenotypes for Identification of Immunosuppression Related Complications in Kidney Transplant Recipients within the Patient-Centered Clinical Research Network Joshua Kettelkamp, United States Performance of Computable Phenotypes for Identification of Immunosuppression Related Complications in Kidney Transplant Recipients within the Patient-Centered Clinical Research Network
16:30-17:45	155	155 16:30 Oral Abstract: Kidney: Surgical Innovation and Organ Assessment Full Details DEVPRAKASH CHOUDHARY, India Optimizing Outcomes in 2200 Pure-Laparoscopic Living Donor Kidney Transplants: The Largest Single-Center Analysis of Single vs. Multiple Renal Arteries DEVPRAKASH CHOUDHARY, India Optimizing Outcomes in 2200 Pure-Laparoscopic Living Donor Kidney Transplants: The Largest Single-Center Analysis of Single vs. Multiple Renal Arteries Simone Zaragoza, United States Robotic versus Laparoscopic Living Donor Nephrectomy: Advancing Minimally Invasive Techniques for Optimized Donor Outcomes Simone Zaragoza, United States Robotic versus Laparoscopic Living Donor Nephrectomy: Advancing Minimally Invasive Techniques for Optimized Donor Outcomes Hafiz Umair Siddiqui, United States Comparative Outcomes of Single-Port vs. Multi-Port Robotic Kidney Transplantation for Living and Deceased Donor Hafiz Umair Siddiqui, United States Comparative Outcomes of Single-Port vs. Multi-Port Robotic Kidney Transplantation for Living and Deceased Donor DEVPRAKASH CHOUDHARY, India Identifying Early Injury Biomarkers in Living Donor Kidney Perfusion Fluid: Unveiling the Role of Tissue-Resident Immune Cells DEVPRAKASH CHOUDHARY, India Identifying Early Injury Biomarkers in Living Donor Kidney Perfusion Fluid: Unveiling the Role of Tissue-Resident Immune Cells Annaliese Ionson, United States The Evolution of Kidney Auto-Transplant: Single-Center Experience Transitioning from Open to Single-Port Robotic Approach and Impact on Perioperative Outcomes Annaliese Ionson, United States The Evolution of Kidney Auto-Transplant: Single-Center Experience Transitioning from Open to Single-Port Robotic Approach and Impact on Perioperative Outcomes Manjunath Pol, India The Effect of Modified vs Conventional ERAS on Clinical and Graft Outcomes in Kidney Transplant Recipients: Preliminary Results of Randomized Controlled Trial Manjunath Pol, India The Effect of Modified vs Conventional ERAS on Clinical and Graft Outcomes in Kidney Transplant Recipients: Preliminary Results of Randomized Controlled Trial Vinayak Rohan, United States Early Experience with AWAKE Kidney Transplantation Vinayak Rohan, United States Early Experience with AWAKE Kidney Transplantation Harry Robertson, Australia Renal-Agent: The First Artificially Intelligent Autonomous Agent for Renal Pathology Harry Robertson, Australia Renal-Agent: The First Artificially Intelligent Autonomous Agent for Renal Pathology
16:30-17:45	11	11 16:30 Oral Abstract: Artificial Intelligence and Complex Analytics Full Details Chongming Jiang, United States Machine Learning-Based Risk Prediction of Allograft Rejection within One-Year Post-Transplant for Kidney Transplant Patients Chongming Jiang, United States Machine Learning-Based Risk Prediction of Allograft Rejection within One-Year Post-Transplant for Kidney Transplant Patients Agathe Truchot, France Development and Validation of a Prediction Model for Risk of Death in Kidney Transplant Recipients (Mortality Box) Agathe Truchot, France Development and Validation of a Prediction Model for Risk of Death in Kidney Transplant Recipients (Mortality Box) Yingtao Luo, United States On Interpretable Heart Transplant Mortality Prediction and Benchmarking Yingtao Luo, United States On Interpretable Heart Transplant Mortality Prediction and Benchmarking Piyawat Kantagowit, United States A New Prediction Model for Waitlist Survival in Kidney Transplant Candidates Piyawat Kantagowit, United States A New Prediction Model for Waitlist Survival in Kidney Transplant Candidates Yu Kijima, Japan Optimization of a Model for Predicting Renal Function After Living Kidney Transplantation Using Computed Tomography Volumetry Yu Kijima, Japan Optimization of a Model for Predicting Renal Function After Living Kidney Transplantation Using Computed Tomography Volumetry Kazunari Sasaki, United States Development and Validation of a Machine Learning Model to Reduce Futile Donation After Circulatory Death Procurements in Liver Transplantation Kazunari Sasaki, United States Development and Validation of a Machine Learning Model to Reduce Futile Donation After Circulatory Death Procurements in Liver Transplantation Kenji Okumura, United States Development of a HIPAA Compliant Cloud-Based Donor Liver Biopsy Steatosis Assessment Tool Using Artificial Intelligence Technology Kenji Okumura, United States Development of a HIPAA Compliant Cloud-Based Donor Liver Biopsy Steatosis Assessment Tool Using Artificial Intelligence Technology Agathe Truchot, France Impact of Missing Data Imputation Strategies on Performances of Kidney Allograft Failure Prediction Models Agathe Truchot, France Impact of Missing Data Imputation Strategies on Performances of Kidney Allograft Failure Prediction Models
16:30-17:45	10	10 16:30 Oral Abstract: Innovation in Pediatric Liver Transplant Full Details Amanda Jensen, United States Age Matching Improves Graft Survival in Adolescent Liver Transplantation Amanda Jensen, United States Age Matching Improves Graft Survival in Adolescent Liver Transplantation Udeme Ekong, United States Functional Phenotypic Diversity of Regulatory T Cells in Pediatric Liver Transplantation Udeme Ekong, United States Functional Phenotypic Diversity of Regulatory T Cells in Pediatric Liver Transplantation Sarah Maxwell, United States Health Outcomes in Children of Liver Transplant (LT) Recipients Sarah Maxwell, United States Health Outcomes in Children of Liver Transplant (LT) Recipients Amanda Jensen, United States Split Liver Transplantation Using Machine Perfusion in Pediatric Recipients Amanda Jensen, United States Split Liver Transplantation Using Machine Perfusion in Pediatric Recipients Nensi Ruzgar, United States Disparities in Pediatric Liver Transplantation Based on Limited English Proficiency: Trends over 20 Years Nensi Ruzgar, United States Disparities in Pediatric Liver Transplantation Based on Limited English Proficiency: Trends over 20 Years Jennifer Halma, United States Consensus Treatment Plans: A Novel Collaborative Effort to "Right Size" Immunosuppression After Pediatric Liver Transplant Jennifer Halma, United States Consensus Treatment Plans: A Novel Collaborative Effort to "Right Size" Immunosuppression After Pediatric Liver Transplant
16:30-17:45	12	12 16:30 Oral Abstract: Islet Full Details Balamurugan Appakalai, United States Preserving Human Pancreatic Microvessel Fragments with Islets during Transplant Improved Islet Engraftment and Diabetes Reversal: Crosstalk Signaling Mechanisms That Regulate Intra-Islet Endothelial Cells Survival and Islet Microcirculation Balamurugan Appakalai, United States Preserving Human Pancreatic Microvessel Fragments with Islets during Transplant Improved Islet Engraftment and Diabetes Reversal: Crosstalk Signaling Mechanisms That Regulate Intra-Islet Endothelial Cells Survival and Islet Microcirculation Joseph Sushil Rao, United States Clinical Scale Cryopreservation of Human Deceased Donor Islet and Stem Cell-Derived Beta Clusters by Vitrification for Allotransplantation in Type I Diabetes Joseph Sushil Rao, United States Clinical Scale Cryopreservation of Human Deceased Donor Islet and Stem Cell-Derived Beta Clusters by Vitrification for Allotransplantation in Type I Diabetes qin yang, United States Development of Non-Human Primate Stem Cell-Derived Islets for Allogeneic Transplantation qin yang, United States Development of Non-Human Primate Stem Cell-Derived Islets for Allogeneic Transplantation Bashoo Naziruddin, United States Generation of Functional Islet Cell Organoids from Adult Multipotent Islet Progenitor Cells Captured during Islet Cell Isolation Procedures Bashoo Naziruddin, United States Generation of Functional Islet Cell Organoids from Adult Multipotent Islet Progenitor Cells Captured during Islet Cell Isolation Procedures qin yang, United States Evaluation of Optimal Engraftment Sites for Human Stem Cell-Derived Islets in a Non-Human Primate Model qin yang, United States Evaluation of Optimal Engraftment Sites for Human Stem Cell-Derived Islets in a Non-Human Primate Model Catherine Parmentier, Canada Simultaneous Islet-Kidney Transplantation as an Alternative for Patients Ineligible for Pancreas Transplant: Initial Experience at a North American Transplant Center Catherine Parmentier, Canada Simultaneous Islet-Kidney Transplantation as an Alternative for Patients Ineligible for Pancreas Transplant: Initial Experience at a North American Transplant Center Meghan Hu, United States A Comparison of Depletional Induction Strategies on Non-Human Primate Islet Xenotransplantation Outcomes Meghan Hu, United States A Comparison of Depletional Induction Strategies on Non-Human Primate Islet Xenotransplantation Outcomes
18:00 - 19:00 \| Town Hall
18:00-19:00	201	201 18:00 Town Hall: TTS Townhall Full Details John Fung, United States Welcome & Overview John Fung, United States Welcome & Overview John Fung, United States Select TTS Highlights John Fung, United States Select TTS Highlights Randall Morris, United States Randy Morris - TY Randall Morris, United States Randy Morris - TY WTC 2025, Singapore WHO Video WTC 2025, Singapore WHO Video Medhat Askar, Qatar WHO & TTS Highlights & Projects Medhat Askar, Qatar WHO & TTS Highlights & Projects Medhat Askar, Qatar WHO & GDHC - Moving into the Future Medhat Askar, Qatar WHO & GDHC - Moving into the Future

07:00-08:00

11

07:00

Invited Symposia: Eplet Matching: Hype or the Way to the Transplant Lasting a Lifetime – A Debate

Full Details

Peter Nickerson, Canada
Pro

Anat Tambur, United States
Con

07:00-08:00

25

07:00

Invited Symposia: Stopping the Inevitable? Approaches to Respiratory Viruses

Full Details

Michael Ison, United States
Exploring the Therapeutic Pipeline for Respiratory Viruses

Victoria Hall, Canada
Update on Vaccinations to Prevent Respiratory Viral Infections

Nancy Law, United States
Pre-Exposure and Post-Exposure Prophylaxis for Respiratory Viruses

07:00-08:00

4

07:00

Invited Symposia: Recurrent Glomerular Disease Post Kidney Transplant: Navigating the New Landscape, New Frontiers in FSGS, and Membranous Nephropathy, Session I

Full Details

Leonardo Riella, United States
The Changing Landscape and Understanding of Recurrent Glomerular Disease After Kidney Transplantation

Mireille El Ters, United States
Membranous Nephropathy Post Kidney Transplant

Nada Alachkar, United States
FSGS-Recurrence: Latest Advances in Genetic Screening, Novel Immunosuppressive Strategies, Precision Approaches

07:00-08:00

155

07:00

Invited Symposia: Overcoming Structural and Societal Barriers to Organ Donation

Full Details

Sanjay Nagral, India
What Steps Need to Be Taken to Advance Equitable Deceased Donor Transplant in India?

Elmi Muller, South Africa
Travelling for Transplant - How to Provide Care for Recipients and Donors Who Travel for Transplantation

Axel Rahmel, Germany
Deceased and Living Donation in Europe - Which Countries Are Making Progress and Why ?

07:00-08:00

10

07:00

Invited Symposia: Tell Me More About That: How to Do Qualitative Research in Transplantation

Full Details

Karen Vanterpool, United States
Designing, Conducting, and Publishing Qualitative Interview Studies

Rachel Patzer, United States
The Future of Qualitative Research in the Era of AI

Elisa Gordon, United States
Best Papers in Transplant Qualitative Research

07:00-08:00

22

07:00

Invited Symposia: Exploring the Immune Impact of Frailty and Aging on Solid Organ Transplant Recipients

Full Details

Jennifer Lai, United States
Effect of Physical Frailty and Aging on Recipient Outcomes in Solid Organ Transplantation

Joanna Schaenman, United States
Frailty and Its Association with Immune Dysfunction in Transplant Recipients

Stefan Tullius, United States
Impact of Immune Aging and Senescence on the Generation of the Alloimmune Response of Solid Organ Transplant Recipients

07:00-08:00

154

07:00

Invited Symposia: Highway Guardrails: Organ Transplantation with Kidney Safety Net

Full Details

Giselle Guerra, Brazil
Preventing Highway Robbery: Kidney Transplant Perspective on Safety Nets

Mark Russo, United States
Highway to Heaven: Kidney Utilization and Outcome after Liver Transplant

Shelley Hall, United States
On the Road Again: The Journey of Heart Kidney Transplant and Safety Net Timing

07:00-08:00

24

07:00

Invited Symposia: Ancestry-Specific Variation in the Apolipoprotein L1 Gene (APOL1) and Kidney Transplant Outcomes

Full Details

Barry Freedman, United States
Overview of the Current Status of the NIH Study 7 Years Later

Krista Lentine, United States
Exploring Solutions to Ethical Challenges of APOL-1 Testing

Chi-Yuan Hsu, United States
Living Donor Extended Time Outcomes (LETO Study)

Akinlolu Ojo, United States
APOL1 Bi and Monoallelic Variants and Chronic Kidney Disease in West Africans

07:00-08:00

9

07:00

Invited Symposia: Current Status of Uterus Transplantation

Full Details

Kathleen O'Neill, United States
Cost-Effectiveness of Uterine Transplant Versus Other Pathways to Parenthood

Liza Johannesson, United States
Uterus Transplantation - Current State and Future Application

Ann Kataria, United States
Unique Aspects of the Immune Response in Uterus Transplantation

07:00-08:00

12

07:00

Rapid Fire Oral Abstract Session: Fundamentals of Transplantation Science

Full Details

Joe Douglas, United States
Use of BMT CTN 1202 Study Samples to Identify Prognostic Biomarkers for Chronic Graft-versus-Host Disease with Peripheral Blood Hematopoietic Cell Transplant Recipients

Chengguo Wei, United States
Genetic Polymorphisms of LILRB3 Drive Monocyte-Mediated Inflammation in Acute Kidney Injury

Chao Yang, People's Republic of China
Integrated Multi-Omics and Murine Models Identify CSF1 as a Therapeutic Target in Chronic Allograft Rejection Following Kidney Transplantation

Sara Kazeminia, United States
Synergistic Effects of MKK4 Inhibitor and Ex Vivo Gene Therapy on Liver Regeneration in a Porcine Model of FAH Deficiency: Progress Towards Human Liver Production in Chimeric Pigs

Mustafa Nazzal, United States
The Use of Nanocomposite Materials Tagged with Deferoxamine to Facilitate Iron Chelation and Mitigation of Ferroptosis and Ischemia Reperfusion Injury of Livers Using Novel Normothermic Perfusion Pump

Ramiah Caine, United States
Single-Cell RNA/TCR Sequencing: Do Urinary CD8+ T Cell Populations Accurately Reflect Transcriptional Profiling of Allograft Infiltrating CD8+ T Cell Populations?

Sandra Lindstedt, Sweden
Exogenous Mitochondrial Therapy during Machine Perfusion Restores the Function of Livers Donated After Circulatory Death A Cross-Circulation Evaluation for Clinical Transplantability

07:00-08:00

20

07:00

Rapid Fire Oral Abstract Session: Hot Topics in Heart Transplantation

Full Details

David D'Alessandro, United States
Heart Transplantation from Donation After Circulatory Death Donors: Comparison of the OCS Heart and Non-OCS Methods

Yasuhiro Shudo, United States
Over 1,000 Heart Transplants Using Donation After Circulator Death (DCD) Donors: Real-World Experience with the Organ Care System (OCS) Heart

Vincent Mauduit, United States
Large Heart Transplant Meta-Analysis Reveals Several New Genetic Associations with Post-Transplant Outcomes

Achilles Aiken, United States
Outcomes of C1q Positive De Novo Donor-Specific Antibodies Following Heart Transplantation

Jeremy Birkmire, United States
A Novel Donor-Recipient Risk Index to Predict Short-Term Outcomes in Pediatric Heart Transplantation

Jon Kobashigawa, United States
Does the Binding Strength of Multiple Donor Specific Antibodies Crossed at the Time of Heart Transplant Impact Post-Transplant Outcomes?

Peter Chin, United States
Long-Term Outcomes of Total Lymphoid Irradiation (TLI) Following Pediatric Heart Transplantation

Morgan Baughman, United States
Evaluation of the Long-Term Outcomes of Hypomagnesemia Post Heart Transplantation

07:00-08:00

23

07:00

Rapid Fire Oral Abstract Session: Graft Under Pressure: Navigating BK Virus

Full Details

Ambreen Azhar, United States
Molecular and Histological Insights into BK Virus-Associated Nephropathy in Kidney Transplant Recipients

Ambreen Azhar, United States
"Immune Predictors of BK Viremia Clearance: Role of BK Virus-Specific T-Cell Immunity in Kidney Transplant Recipients"

Elizabeth Hendren, Canada
Changes in the Duration and Severity of BK Viral Load May as a Surrogate Outcome in Trials to Advance New Therapeutics for BK Virus

Matthew D'Costa, Singapore
Intravenous Immunoglobulin as Adjunctive Treatment for BK DNAemia

Hye Eun Kwon, Korea
Comparative Analysis of Immunosuppressant Adjustments in BK Viremia Management: Sirolimus, Leflunomide, and MMF Tapering

Alexis Piedrafita, France
RNASeq Changes Associated with Polyomavirus-Associated Nephropathy: From Pathophysiology to Drug Repurposing

Hsu-Han Wang, Taiwan
Adding on mTOR Inhibitors May Help Reducing Viral Load in BK Polyomavirus Infection After Kidney Transplantation

Nicole Clarke, United States
The Risk Factors Developing BK Viraemia and Its Viral Kinetics in Kidney Transplant Recipients

07:00-08:00

153

07:00

Rapid Fire Oral Abstract Session: Deceased Donor Kidney Allocation

Full Details

John Montgomery, United States
Obesity and Access to Out-of-Sequence Deceased Donor Kidney Transplantation

Tainá Sandes-freitas, Brazil
Pretransplant Virtual Epitope-Based Crossmatch is Associated with Worse Outcomes After Kidney Transplantation

Kenneth Andreoni, United States
CPRA Sensitization Priority: The Need to Recalculate After Implementation of 250 nm Sharing Circles

Maria Kaisar, United Kingdom
Plasma Uromodulin Dynamics in Deceased Donors: A Marker of Tubular Integrity for Post-Transplant Kidney Function

Jennifer Philip, United States
Hypothermic Machine Perfusion Parameters Are Associated with Donor Characteristics and Post-Transplant Outcomes in Deceased Donor Kidney Transplant

Krista Lentine, United States
A Pilot Randomized Trial of Approaches to Deceased Donor Kidney Procurement Biopsies: Operational Challenges and Lessons Learned

Douglas Keith, United States
Taking One for the Team, Should the Time Limit for Reinstatement of Waiting Time After Early Graft Loss Be Extended?

07:00-08:00

8

07:00

Rapid Fire Oral Abstract Session: Kidney: Cardiometabolic Issues

Full Details

Cayden Lawrence, United States
Association of Right Ventricular Strain with Cardiovascular Outcomes in Kidney Transplant Recipients

Daniel Huck, United States
Interplay of Inflammation, Dysregulated Angiogenesis, and Coronary Microvascular Dysfunction Among Patients Being Evaluated for Kidney Transplant

Khang Nguyen, United States
Pre-Transplant Revascularization Reduces Post-Kidney Transplant Major Adverse Cardiovascular Events

Suwasin Udomkarnjananun, Thailand
The Effect of Kidney Allograft Rejection on Post-Transplant Cardiovascular Complications

Andrew Bentall, United States
The Impact of Anticoagulation on Post-Transplant Complications - Impact on Deceased Donor Recipients

Tatenda Mupfudze, United States
The Impact of Obesity and Health Insurance on Kidney Transplantation and Waiting List Mortality

Ophelia Yin, United States
Preeclampsia in Kidney Transplant Recipients during Pregnancy and Its Impact on Graft Survival

Henry Zelada, United States
Tolerability of Glucagon-Like Peptide 1 Receptor Agonists (GLP1-RA) in Kidney Transplant Recipients with Diabetes

07:00-08:00

21

07:00

Late-Breaking Oral Abstract: Transplantation: Patient Access and Provider Perceptions

Full Details

Francisco J. Reyna Sepulveda, Mexico
Recovery Without Equity: The Complex Post-COVID Landscape of Transplantation in Mexico

Vivek Kute, India
Analysis of Kidney and Liver Exchange Transplantation in India (2000-2025): A Multicentre, Retrospective Cohort Study

Francisco J. Reyna Sepulveda, Mexico
Strategic Insights into Organ Donation: Analyzing Perceptions, Attitudes, and Disincentive Removal Effects

Lijamol Joseph, United Arab Emirates
Consent and Complexity: Organ Donation Decisions in a Multicultural UAE Organ Donation Program HAYAT

Francisco J. Reyna Sepulveda, Mexico
When Biology Meets Bureaucracy: Organ Waiting Times of Deceased Donor Organ Transplantation. 13 Years of Transplants in Mexico

Manpreet Samra, United States
Transplant Professionals Perception Towards Age and Solid Organ Transplant: Survey Results

08:15-09:30

10

08:15

Invited Symposia: An Update from TPAC (Transplant Pharmacy Adherence Consortium) on Transplant Adherence Sharing Published Experiences and Lessons Learned

Full Details

Ann Kataria, United States
TRAMM Tool 2.0: Tips for Practice Utilization and EMR Integration

Krysta Walter, United States
Share Strategies to Implement the Newly Developed Transplant Medication Adherence Videos Within Your Clinical Practice

Tiffany Kaiser, United States
Technology-Based Adherence Solutions

08:15-09:30

22

08:15

Invited Symposia: Cell Therapy – Novel Approaches to Refine Immunosuppression and Immunity

Full Details

Leslie Kean, United States
OX40l CAR-Directed Treg: Biology and Clinical Implications

Nalan Utku, Germany
Translating TIRC7 Expressing Treg to the Clinic

Angus Thomson, United States
Using DC Regulatory Cells in Humans

Susan Prockop, United States
Adoptive Cell Therapy for Viral Infection in Transplant Recipients

08:15-09:30

154

08:15

Invited Symposia: Multi-drug-resistant Organisms: Challenging Cases

Full Details

Paolo Grossi, Italy
Panelist

Priscilla Rupali, India
Panelist

Saima Aslam, United States
Panelist

Ghadeer Al-Ahmadi, Saudi Arabia
Panelist

08:15-09:30

12

08:15

Invited Symposia: Multiorgan Transplantation in Pediatrics

Full Details

Armando Ganoza, United States
Indications/Outcomes/Future Directions of Pediatric Multiorgan Transplant

Swati Choudhry, United States
Simultaneous Peds Heart/Kidney - When to Pull the Trigger

Lars Pape, Germany
Combined Liver/Kidney Transplantation for Children

Anji Wall, United States
Ethical Considerations for Multiorgan Transplantation in Children

08:15-09:30

11

08:15

Invited Symposia: International Selection Panel for Lung Transplant

Full Details

Jasleen Kukreja, United States
Panelist

Robin Vos, Belgium
Panelist

Marie Budev, United States
Panelists

Konrad Hoetzenecker, United States
Panelists

08:15-09:30

153

08:15

Invited Symposia: The Global Perspective on Organ Donation

Full Details

Mohamed Rela, India
Living Liver Donation

Emily Vail, United States
Donor Care Centers

Axel Rahmel, Germany
Deceased Organ Donation

Vivekanand Jha, India
Living Kidney Donation

08:15-09:30

25

08:15

Invited Symposia: Clinical Trials: How Do We Promote Innovation?

Full Details

Amit Sharma, India
Industry Perspective / Precision Medicine-Based Trials

Roshan George, United States
PROMs

Michael Collins, Australia
Faster Cheaper Better Trials

Laura Esserman, United States
Innovative Trial Designs

08:15-09:30

21

08:15

Invited Symposia: Role of Robotics in Transplantation: Are We Ready for Prime Time?

Full Details

Dieter Broering, Saudi Arabia
Advances in Robotic Liver Transplantation: The Recipient

Jesse Davidson, United States
Advances in Robotic Kidney Transplantation: The Donor

Pier Giulianotti, United States
The Next Frontiers in Minimally Invasive Surgery for Transplantation

Yee Lee Cheah, United States
Advances in Robotic Liver Transplantation: The Donor

Phillipe Abreu, United States
Advances in Robotic Kidney Transplantation: The Recipient

08:15-09:30

20

08:15

Invited Symposia: Prehabilitation: A Proactive Approach to Improving Transplant Outcomes

Full Details

Jan Larmann, Germany
Anesthetic Considerations to Optimize Post-transplant Recovery

Christine Liu, United States
Frailty in Kidney Transplant Recipients

Babak Orandi, United States
Perioperative Considerations in Older Recipients

Tania Janaudis Ferreira, Canada
Updates in Innovations in Prehabilitation for Solid Organ Transplant Recipients

08:15-09:30

155

08:15

Invited Symposia: Making It Easier: Removing Disincentives and Barriers from Live Donation

Full Details

Dempsey Hughes, United States
Living Donor Protection Act

Syed Husain, United States
Financial Neutrality for Living Donors - NLDAC, LDCOE and Other Governmental Programs

Carrie Thiessen, United States
Crowdfunding for Living Donors?

Deirdre Sawinski, United States
Improving the Efficiency of Living Donor Process

08:15-09:30

24

08:15

Invited Symposia: Manipulation of Organs During Machine Perfusion

Full Details

Seyed Alireza Rabi, United States
Mending Broken Hearts: Organ Reconditioning for Transplantation Using siRNA-based Therapies During Ex Vivo Machine Perfusion

Sandra Lindstedt, Sweden
Ex Vivo Lung Reconditioning: Xenotransplantation of Mitochondria

Rohit Gaurav, United Kingdom
Opportunities to Optimize Livers During Perfusion: The Role of Sequential Perfusion Technology

Leonie van Leeuwen, United States
Ex Vivo Kidney Modulation: Opportunities for Drug Delivery and Organ Repair

08:15-09:30

8

08:15

Invited Symposia: Harnessing AI for Efficiency and Precision in Transplantation

Full Details

Mamatha Bhat, Canada
AI: How It’s Going: Clinical Decision Making

Allan Kirk, United States
AI: Where It Could Lead Us

Antony Attia, United States
AI: How it Started

Leyla Warsame, United States
AI: How It’s Going: Health Systems AI Governance

08:15-09:30

9

08:15

Invited Symposia: Current Status of Hand and Face Transplantation

Full Details

L. Scott Levin, United States
Hand Transplantation - Past, Present, and Future - Is It Time for Standard of Care?

Linda Cendales, United States
The Role of NASEM in Validating Hand and Face Transplant in the USA

Bruce Gelb, United States
Unique Aspects of Immunosuppression in Face and Hand Transplant

Laurent Lantieri, France
Face Transplantation - Past Present and Future

08:15-09:30

4

08:15

Invited Symposia: Innovations to Expand Living Kidney Donation

Full Details

Matt Cooper, United States
Kidney Paired Donation

Justin Gill, Canada
Advanced Donation and Reciprocity-Based Strategies

Elisa Gordon, United States
Elimination of Financial Disincentives / Incentives

Jim Rodrigue, United States
From Stagnation to Transformation: A Multisystem Strategy for Growth

08:15-09:30

23

08:15

Invited Symposia: Transplant Oncology: Challenges and Innovation

Full Details

Naoka Murakami, United States
Challenges and Innovation of Transplant Onconephrology

Anjana Pillai, United States
Transplant Oncology - Liver: Challenges and Strategies to Advance the Field

Ankit Bharat, United States
Challenges and Opportunities in Thoracic Transplant Oncology

10:00-10:30

Plenary

10:00

The Health Misinformation Crisis! - Timothy Caulfield

Full Details

Timothy Caulfield, Canada
The Health Misinformation Crisis!

10:30-11:30

Plenary

10:30

Plenary: Plenary Abstracts 1

Full Details

Imad Aljabban, United States
Longest Surviving Recipient of a Xenotransplant: Allo-Sensitized Patient Receiving a 10 Gene-Edited Pig  Kidney

David Taber, United States
Burdens of Therapy: AST’s National Patient Survey of Unmet Immunosuppressant Needs

Tao Luo, People's Republic of China
Ischemia-Free Procedure Reshapes the Local and Systemic Immunity in Liver Transplantation

Victor Ferreira, Canada
Virus-Inclusive Single-Cell RNA Sequencing Reveals Broad Cellular Tropism and Common Pathway Dysfunctions Linked to Cytomegalovirus Infection in Organ Transplant Recipients

11:30-12:45

Plenary

11:30

Presidential Addresses: AST Presidential Address & Society Awards

Full Details

AST WTC2025, United States
Set Up Stage

David Foley, United States
Presidents Address - Introduction

Jon Kobashigawa, United States
Presidential Speech

Jon Kobashigawa, United States
Lifetime Achievement Awards

David Foley, United States
Grant Awards - Career Development Grants

David Foley, United States
Grant Awards - Career Transition Awards

David Foley, United States
Grant Awards - Priority Grants

David Foley, United States
AJT Awards

Sandy Feng, United States
AJT Awards

AST WTC2025, United States
Closing Announcements & Photos

12:15-15:30

12

12:15

Invited Symposia: Mechanisms of Antibody Mediated Rejection

Full Details

Emmanuel Zorn, United States
Intra-Graft B Cell Populations After Heart Transplantation

Peter Sage, United States
Control of Antibody Mediated Rejection by CD4+ Follicular T Populations

David Allman, United States
Formation and Maintenance of Graft-Specific Plasma Cells

Christian Larsen, United States
Identification of Epitopes Associated With Indirect Alloreactivity

12:15-15:30

10

12:15

Invited Symposia: Empowering Care Teams: Allied Health-Led Multidisciplinary Clinics for Transplant Patients

Full Details

Darnell Mompoint-Williams, United States
Breaking Boundaries: APP-Led Specialty Clinic for ABO Incompatible and HIV-Positive Transplant Patients

Jillian Fose, United States
Guardians of Immunity: Pharmacy-Led CMV Stewardship for Transplant Recipients

Janice Kerr, United States
Too Sweet: Pharmacy-Led Post-Transplant Diabetes Management Clinic

Staci McKean, United States
Decoding the Tower of Babel in Rejection: APP-Led Initiative in Complex Immunologic Cases

12:15-15:30

155

12:15

Invited Symposia: Heart Transplant Selection Criteria: Urban Legends, Myths, and Lies (Where's the Data?)

Full Details

Eileen Hsich, United States
Panelist

Seyed Alireza Rabi, United States
Panelist

Anne Dipchand, Canada
Panelist

Shelley Hall, United States
Panelist

Pedro Catarino, United States
Panelist

12:15-15:30

24

12:15

Invited Symposia: The ABCs of CMV

Full Details

Atul Humar, Canada
CMV Prophylaxis vs Pre-emptive Therapy

Raymund Razonable, United States
New Approaches for Treatment

Deepali Kumar, Canada
Moving Forward with CMV Cell-mediated Immunity

Camille Kotton, United States
Introduction to the New International Consensus Guidelines

12:15-15:30

25

12:15

Invited Symposia: Update on OPTN in the United States

Full Details

Richard Formica, United States
Don’t Throw the Baby Out with the Bathwater

Silke Niederhaus, United States
Patient Perspectives from Within the Field

Jeffrey Crippin, United States
The History of the OPTN and its Accomplishments

Rexanah Morrissette, United States
Previous Experience on OPTN

12:15-15:30

154

12:15

Invited Symposia: Nonutilization: How Do We Flip the Switch to Increase Utilization?

Full Details

Peter Reese, United States
Is Non-use Mainly a US Problem?

Axel Rahmel, Germany
Perspective on Utilization From Other Parts of the World

Darren Stewart, United States
Factors Contributing to Nonuse in the US

12:15-15:30

4

12:15

Invited Symposia: Non-invasive Biomarkers for Monitoring Kidney Transplant Recipients

Full Details

Enver Akalin, United States
Comparison of Different Blood Transcriptomics for Rejection or Immune Quiescence

Jamil Azzi, United States
Urinary Exosomes and Transcriptomics for Diagnosis of Rejection

Alexandre Loupy, France
The IBOX Prognostication System

Klemens Budde, Germany
Clinical Utility of Donor-Derived Cell-Free DNA Monitoring After Kidney Transplant

12:15-15:30

23

12:15

Invited Symposia: Intestinal Transplantation Around the World: Updates and Perspectives

Full Details

Cal Matsumoto, United States
North America

Francisco Hernandez Oliverios, Spain
Europe

Ehab Abufarhaneh, Saudi Arabia
Middle East

Guosheng Wu, People's Republic of China
Asia

Adam Testro, Australia
Oceania

Gabriel Gondolesi, United States
South America

12:15-15:30

21

12:15

Invited Symposia: Working Beyond Borders: It Takes an International Village

Full Details

Stefano Bertozzi, United States
The Pharmaceutical Industry’s Role in Expanding Global Health Initiatives

David Thomson, South Africa
Developing Deceased Organ Donation in Africa

Jeffrey Punch, United States
How Can Developed Countries Best Help Developing Countries?

Vivekanand Jha, India
Beyond Who: Enabling Global Capacity and Expertise

12:15-15:15

11

12:15

Invited Symposia: Sex in Transplantation

Full Details

Friederike Martin, United States
Impact of Hormones and Hormonal Receptors on Autoimmunity

ANDREW MALONE, Ireland
Loss of Y: Implications for Transplantation

Shannon Dunn, Canada
Sex Differences in Immune Responses

12:15-15:15

20

12:15

Invited Symposia: Debrief of the First Annual DEI in Transplant Conference: Charting the Path Toward Equity in Transplantation

Full Details

Lisa McElroy, United States
Gender, Racial, and Age Disparities Amongst Solid Organ Transplant Recipients

Heather Badenoch, Canada
Gift of Life: Navigating the Journey to Find a Live Donor

Nigel Girgrah, United States
Transforming Healthcare Systems to Support Transplant Professionals

12:15-15:15

22

12:15

Invited Symposia: Mens Sana in Corpore Sano - The Underappreciated Issues of Mental Health in Transplant

Full Details

Paula Zimbrean, United States
Incorporating Tools to Assess Mental Health and Cognitive Function in the Transplant Evaluation

Makayla Cordoza, United States
Assessing and Managing Post-transplant Delirium

Ken Lotherington, Canada
Caregiver Fatigue and Burnout

12:15-15:30

8

12:15

Invited Symposia: How to Optimise a More Global Research Infrastructure Redefining the Clinical and Scientific Landscape in the Era of AI

Full Details

Maria Kaisar, United Kingdom
Fingerprinting the Donor and Organ Quality Predicting Post Transplant Outcomes

Brendan Keating, United States
Genetic and Other Recipient Factors Impacting Success in Transplantation

Maria Kaisar, United Kingdom
Panelist Plus 1 Minute Vision Statement: Platform Development and Collaboration (QUOD Perspective)

Brendan Keating, United States
Panelist Plus 1 Minute Vision Statement: Integrated Bioresources and AI - iGeneTRAIN Perspective

Chris Jaynes, United States
Panelist Plus 1 Minute Vision Statement: Integrated Bioresources and AI - KIT-GENIE Perspective

Anthony Langone, United States
Panelist Plus 1 Minute Vision Statement: Role and Vision of NIH of Integrated Bioresources and AI

Antonio Gomes, Netherlands
A Robust Snapshot of Relevant Donor and Recipients Factors in Kidney Transplantation

12:15-15:30

9

12:15

Late-Breaking Oral Abstract: Liver Transplantation and Machine Perfusion

Full Details

Michelle Nguyen, United States
Normothermic Machine Perfusion Equalizes Graft Survival in DCD and DBD Liver Transplantation

Khaled Ali, United States
Are the Flows Sufficient? Potential of Oxygen Extraction Ratio during Normothermic Machine Perfusion of Human Liver Grafts as a Marker of Perfusion Quality.

Michelle Nguyen, United States
Low Bile Output During Normothermic Machine Perfusion Is Not Predictive of Poor Graft Outcomes

Valberto Sanha, United States
The Impact of Routine Application of Normothermic Machine Perfusion in Liver Transplantation: Making the Unacceptable Acceptable

Dharesh Raj Amarnath, United Kingdom
Donor Time to Death and DCD Liver Transplant Outcomes: Challenging the Dogma that Shorter is Better

Alissa Cutrone, United States
Normothermic Machine Perfusion of Moderately Steatotic Livers

Geofia Crasta, United States
Novel Approach to Viability Assessment of Split Liver Grafts Using Hypothermic Oxygenated Perfusion

Marco Maria Pascale, Italy
Clinical and Logistical Impact of Machine Perfusion in a Low Volume Liver Transplant Center

16:30-17:45

9

16:30

Oral Abstract: Next-Gen Biomarkers

Full Details

Kevin Louis, France
Innate-Like CD8 T Cell Response to Kidney Graft: A Multimodal Profiling Study of Transplant Rejection

Philip Halloran, Canada
Cellular Deconvolution of Microarray Data from Transplant Biopsies Predicts a Central Role for CD3/CD28 Stimulated CD4 Memory T Cells in Human T Cell-Mediated Rejection in All Organ Transplants

Raphaela Bento, United States
Early Reporting of Transplant Rejection: Genetically Engineered ‘Smart-Organs’ Featuring Diagnostic Capabilities

Avery Fortier, United States
Metabolomic Signatures of Perfused Livers Reveal Early Evaluation May Be Superior

Evgenia Preka, France
Urinary and Blood mRNA Biomarkers for Detecting Kidney Allograft Rejection (The KTD-Innov Study: NCT03582436)

Sarah Tsou, United States
Immune-Metabolism in Acute Heart Transplant Rejection: A Metabolomics Approach to Biomarker Identification in Mice

Alexander Kroemer, United States
Circulating, Cell-Free Methylated DNA Indicates Cellular Sources of Allograft Injury After Liver Transplant

16:30-17:45

24

16:30

Oral Abstract: Xenotransplantation: Pushing Boundaries

Full Details

Qian Guo, United States
Longitudinal Multi-Omics Profiling Reveals Molecular Responses in a Living Human Receiving a Gene-Edited Pig Kidney Xenograft

Kiana Moi, United States
Comprehensive Long-Read Whole Genome Sequencing in 7 Human Xenotransplant Recipients

M. Esad Gunes, United States
GLP Preclinical Trial of Pig-to-Baboon Thymokidney Xenotransplantation Using Inbred GalT-KO Miniature Swine Donors

Bryar Hansen, United States
Blockade of CD40 with or without CD11b versus CD154 Blockade in GTKO and hCD55 Transgenic Pig-to-Macaque Kidney Xenotransplantation

Valentin Goutaudier, France
Spatial Multimodal Characterization of Long-Term Immune Response After Pig-to-Human Kidney Xenotransplantation

Mercy Rophina, United States
Urinary Single-Cell RNA Sequencing from a Pig Kidney to Living Human Xenotransplantation Reveals Dynamic Cellular Changes

SHU LI, United States
Incompatibility of Porcine Endothelial Cell-Derived Extracellular Vesicles and Human Endothelial Cells

Ivy Rosales, United States
Systemic Transfer of Endothelial Molecules of Recipient Origin to Pig Kidney Xenograft Endothelium

16:30-17:45

4

16:30

Oral Abstract: Cytomegalovirus: Antivirals and Immune Defense

Full Details

David Taber, United States
6-Month Outcomes of a Randomized Controlled Trial Comparing the Tolerability and Efficacy of Maribavir vs. Valganciclovir for CMV Prophylaxis in High-Risk Kidney Transplant Recipients

IRFAN MOINUDDIN, United States
CMV T-Cell Immunity Assay Based Guidance to Interrupt Prophylaxis in Intermediate Risk Kidney Transplant Patients

Kennedy Concannon, United States
Low-Dose Valganciclovir for Primary Cytomegalovirus Prophylaxis After Heart Transplant

Chelsea Morinishi, United States
Risk Factors and Real-World Implications of CMV Resistance Mutations After Treatment with Maribavir or Foscarnet for Resistant and Refractory CMV

Franco Citterio, Italy
Prevention of CMV and BKV in De Novo Kidney Transplant Recipients Immunosuppressed with the Combination of Low Dose Tacrolimus and Everolimus

Zachary Yetmar, United States
Effect of Secondary Prophylaxis on the Risk of Recurrent Cytomegalovirus Infection Among Solid Organ Transplant Recipients

Bongha Shin, United States
Impaired CMV-Specific CD8⁺ T Cell Responses Correlate with Increased CMV Viremia in Kidney Transplant Recipients: A Comparative Analysis of Adult and Pediatric Patients

Harry Pickering, United Kingdom
Pre-Viremic, Multi-Omic Immune Signatures of Cytomegalovirus Infection in Kidney Transplant Recipients

16:30-17:45

22

16:30

Oral Abstract: New Frontiers in Lung Transplantation

Full Details

Jianing Fu, United States
Immunogenomic Landscape of T Cell Repertoires After Human Lung Transplantation and Its Clinical Significance

Sho Takemoto, United States
Lung Xenotransplantation Outcomes Using Multi-Gene Edited Pigs: In Vivo Transplant and Ex Vivo Human Xenoperfusion

Rashmi Prava Mohanty, United States
T-Cell Receptor Repertoire Diversity and Change are Associated with Response to Extracorporeal Photopheresis for Chronic Lung Allograft Dysfunction

Philip Halloran, Canada
Molecular Diagnosis of Rejection in Lung Transplant Mucosal Biopsies

Allen Duong, Canada
In Vitro Characterization of Pro-Inflammatory LILRB2+ and Pro-Fibrotic SPP1+ Pulmonary Macrophages in Chronic Lung Allograft Dysfunction

Marta Sablik, France
Banff Human Organ Transplant Panel for Detecting Acute Cellular Rejection in Lung Transplant Biopsies

Bhavya Kapse, United States
Airway Epithelial P53 Expression is a Molecular Driver of Chronic Lung Allograft Dysfunction

Philip Halloran, Canada
Trifecta-Lung Study: dd-cfDNA Correlates with T Cell-Mediated Rejection and Parenchymal Injury in Mucosal Biopsies of Lung Transplants

16:30-17:45

20

16:30

Oral Abstract: The Current Heart Allocation System: Wins and Losses

Full Details

Alyssa Mezochow, United States
Illness Severity Among Heart Transplant Recipients Following 2018 Allocation Change

Amit Alam, United States
Short and Long Term Outcomes Across All Three Heart Transplant Allocation Eras

Najiya Fatma, United States
Waitlist Mortality Risk (US-CRS Score) Distribution Among Status 1 and 2 Adult Heart Transplant Candidates with Exceptions

Stratton Tolmie, United States
Practice Changes at Transplant Centers 5 Years After 2018 US Heart Allocation Policy Change

Daniel Ahn, United States
Low Rates of Dischargeable Left Ventricular Assist Device Placement Following Temporary Non-Surgical Mechanical Circulatory Support Among Status 2 Heart Transplant Candidates

Alina Martinez, United States
Analysis of Time Waiting by Adult Heart Candidates Listed with an LVAD

Joshua Chan, United States
Early versus Late Postoperative Renal Replacement Therapy and Associated Outcomes Following Combined Heart-Kidney Transplantation: A UNOS National Database Analysis

Dhirisha Bhatt, United States
Mortality and Acute Renal Failure Following Simultaneous Heart-Kidney Transplantation (SHK) vs. Heart Transplant Alone (HAT) in Recipients with Moderate to Severe Renal Dysfunction in the United States

16:30-17:45

8

16:30

Oral Abstract: Organ Donation

Full Details

Joaquim Albiol, Spain
Asymmetric Parallelism - The Positive Impact of Transplant Procurement Management Training Programs on Deceased Donation Activity Worldwide

Vijay Subramanian, United States
Why Fly When You Can Drive! - Utilizing Controlled Hypothermic Preservation to Facilitate Long Distance Ground Transportation

Molly White, United States
A Novel Comprehensive Assessment of Transplant Center Offer Acceptance Practices

Ernesto Duarte Tagles, Mexico
Exploring New Ways to Increase Organ Donation Rate, the First Museum of Donation and Transplantation in the World

Kate Rokoss, Canada
Effectively Engaging High School Students About Organ Donation and Transplantation: An Updated on the High School Outreach Initiative Experience

Sharan Alexander, United Arab Emirates
Cross-Border Organ Donation and Transplantation: The UAE Experience in Regional Collaboration with Saudi Arabia and Kuwait

Mustafa Nazzal, United States
The Impact of a Merit Point Incentive System on the Willingness to Donate Among Non-Registered Individuals

Marissa Di Napoli, United States
From Clicks to Compassion: Social Media Use Significantly Drives Altruistic Living Organ Donations in Liver and Kidney Transplantation

16:30-17:45

23

16:30

Oral Abstract: Psychosocial

Full Details

Krista Lentine, United States
Associations of Marijuana Use History with Progression from Living Donor Candidate Evaluation to Approval: Analysis of the US SRTR Living Donor Collective

Natalia Rodriguez-Payan, Mexico
Identifying Risk Factors for Return to Alcohol Use After Liver Transplant

Sarah Hussain, United States
PROMETHEUS: Patient Reported Ethics Outcomes Following Transplants from Donors with or without HIV

Nicolas Muñoz, United States
Financial Burden and Social Needs in Solid Organ Transplant Candidates

Istvan Mucsi, Canada
Health-Related Quality of Life in Kidney Transplant Recipients: Association with Graft Function and Comparison to Patients on Dialysis

José Pestana, Brazil
Validation of the Modified Transplant Symptom Occurrence and Symptom Distress Scale (MTSOSD-59R) in Brazilian Kidney Transplant Recipients

Jesse Schold, United States
Out of Pocket (OOP) Medical Costs for Transplant Recipients Before and After Transplantation

Jingyao Hong, United States
Cognitive Function Impacts Waitlist Mortality Risk for Some but Not All Solid Organ Candidates

16:30-17:45

153

16:30

Oral Abstract: Post Liver Transplant Complications

Full Details

Vadim Jucaud, United States
Vascularized Liver Tissueoid-on-a-Chip: An In Vitro Model for Studying Allograft Rejection

Zeynep DEMIR, France
Molecular Signatures of Rejection in Liver Transplant Biopsies Using the Banff Human Organ Transplant Consensus Gene Panel

Rakesh Sindhi, United States
Single-Cell and Spatial Genomics Reveal T-Cell Priming, Spatially Differentiated Networks and Novel Drug Targets in Early T-Cell-Mediated Liver Transplant (TCMR, LT) Rejection

Min Kyoung Kim, Korea
Clinical Impact of Desensitization in HLA-Incompatible Liver Transplantation: A Propensity Score-Matched Multicenter Analysis

Adnan Sharif, United Kingdom
Major Adverse Cardiovascular Events After Liver Transplantation: An English Population Cohort Analysis

Richard Mangus, United States
Impact of Pre-Liver Transplant Hepatic Encephalopathy and Post-Liver Transplant Altered Mental Status on Post-Transplant Outcomes

Yuqi Dong, People's Republic of China
Ischemia-Free Liver Transplantation Alleviates Post-Transplant Myocardial Injury and Pulmonary Complication: A Post Hoc Analysis from IFLT-DBD Trial

Brooke Rice, United States
Preventing Alcohol Relapse in High-Risk Liver Transplant Recipients: Evaluation of a Multi-Disciplinary Post-Transplant Clinic

16:30-17:45

21

16:30

Oral Abstract: Recurrent Disease and Genetics

Full Details

Andrew Bomback, United States
Pegcetacoplan for Posttransplant Patients with Complement 3 Glomerulopathy or Primary (Idiopathic) Immune-Complex Membranoproliferative Glomerulonephritis

Moreno Rodrigues, United States
Impact of APOL1 Risk Alleles on HIV+ to HIV+ Kidney Transplant Outcomes in South Africa and the United States

Parthenopi Avaniadi, Germany
Daratumumab in Recurrent FSGS After Kidney Transplantation

Marie-Camille Lafargue, United States
Development of a Novel Mouse Model of Focal Segmental Glomerulosclerosis Recurrence Post-Kidney Transplantation Mediated by Anti-Nephrin Antibodies

Francesca Zanoni, Italy
Polygenic Risk Score Predicts IgA Nephropathy Recurrence and Graft Failure in Kidney Transplant Recipients

Frank Hullekes, United States
Recurrence of C3GN and DDD After Kidney Transplantation: TANGO Consortium

Francesca Zanoni, Italy
Genetic Determinants of Kidney Transplant Outcomes: A Large-Scale Multi-Ancestry GWAS Meta-Analysis

Yasar Caliskan, United States
LIMS1 rs893403-GG Genotype and Its Impact on Recurrent/De Novo Glomerulonephritis in Kidney Transplant Recipients

16:30-17:45

25

16:30

Oral Abstract: Deceased Donor Selection/Utilization

Full Details

Douglas Keith, United States
Changes in Donor Quality and Discards over Time: Analysis of Kidney Procurement and Transplantation over the Last 20 Years in the United States

Philip Halloran, Canada
Older Donor Age in Transplanted Kidneys Adversely Impacts the Response to Injury, Increasing Failed Repair

Ondrej Viklicky, Czech Republic
Archetypal Analysis of Deceased Donor Kidneys: A Molecular Approach for Posttransplant Outcomes

Philip Halloran, Canada
Molecular Injury in Deceased-Donor Kidneys at Kidney Removal is Associated with Donor Age, KDPI and with Future Kidney Function (Serum Creatinine)

Hemant Sharma, United Kingdom
Predictors of Kidney Graft Outcomes in Transplants from Acute Kidney Injury Donors - AKI Donor Graft Outcomes Study (ADOPT)

Thomas Dolan, United States
Defining Hard-to-Place Kidney Donors

Hatem Ali, United Kingdom
Equitable Donor Assessment Model (EDAM): A Data-Driven Framework for Stratifying Deceased Donor Kidney Quality

Jimena Alaniz, United States
The Impact of Pre-Transplant Biopsy on Kidney Graft Selection: A Comparative Study in High KDPI Patients

16:30-17:45

154

16:30

Oral Abstract: Kidney: Hot Topics

Full Details

Teresa Po-Yu Chiang, United States
Stop Calling Us!: Preemptive Identification of Kidneys with Virtually Zero Chance of Acceptance

Reza Saidi, United States
Evaluating Outcomes of Preemptive Kidney Transplant in Patients over 65 Using High-KDPI Kidneys Compared to Non-Preemptive Recipients

Marcelo Cantarovich, Canada
Global Survey on Access to Transplantation: Knowledge and Comfort Gaps in the Acceptance of Kidneys from Deceased Donors

Abraham Matar, United States
Eplet Matching Using a Novel Imputational Algorithm Predicts Long-Term Outcomes in Deceased Donor Kidney Transplantation

Lauren Matevish, United States
Delayed Graft Function After Kidney Transplant: Unwanted Complication or Metric of Center Excellence?

David Cron, United States
Association Between Out of Sequence Allocation and Deceased Donor Kidney Non-Utilization Across Organ Procurement Organizations

Elizabeth O'Day, United States
Development and Validation of a Non-Invasive Urinary Metabolite Signature to Differentiate Stable Graft from Graft Injury in Large Scale Multi-Center Study

Joshua Kettelkamp, United States
Performance of Computable Phenotypes for Identification of Immunosuppression Related Complications in Kidney Transplant Recipients within the Patient-Centered Clinical Research Network

16:30-17:45

155

16:30

Oral Abstract: Kidney: Surgical Innovation and Organ Assessment

Full Details

DEVPRAKASH CHOUDHARY, India
Optimizing Outcomes in 2200 Pure-Laparoscopic Living Donor Kidney Transplants: The Largest Single-Center Analysis of Single vs. Multiple Renal Arteries

Simone Zaragoza, United States
Robotic versus Laparoscopic Living Donor Nephrectomy: Advancing Minimally Invasive Techniques for Optimized Donor Outcomes

Hafiz Umair Siddiqui, United States
Comparative Outcomes of Single-Port vs. Multi-Port Robotic Kidney Transplantation for Living and Deceased Donor

DEVPRAKASH CHOUDHARY, India
Identifying Early Injury Biomarkers in Living Donor Kidney Perfusion Fluid: Unveiling the Role of Tissue-Resident Immune Cells

Annaliese Ionson, United States
The Evolution of Kidney Auto-Transplant: Single-Center Experience Transitioning from Open to Single-Port Robotic Approach and Impact on Perioperative Outcomes

Manjunath Pol, India
The Effect of Modified vs Conventional ERAS on Clinical and Graft Outcomes in Kidney Transplant Recipients: Preliminary Results of Randomized Controlled Trial

Vinayak Rohan, United States
Early Experience with AWAKE Kidney Transplantation

Harry Robertson, Australia
Renal-Agent: The First Artificially Intelligent Autonomous Agent for Renal Pathology

16:30-17:45

11

16:30

Oral Abstract: Artificial Intelligence and Complex Analytics

Full Details

Chongming Jiang, United States
Machine Learning-Based Risk Prediction of Allograft Rejection within One-Year Post-Transplant for Kidney Transplant Patients

Agathe Truchot, France
Development and Validation of a Prediction Model for Risk of Death in Kidney Transplant Recipients (Mortality Box)

Yingtao Luo, United States
On Interpretable Heart Transplant Mortality Prediction and Benchmarking

Piyawat Kantagowit, United States
A New Prediction Model for Waitlist Survival in Kidney Transplant Candidates

Yu Kijima, Japan
Optimization of a Model for Predicting Renal Function After Living Kidney Transplantation Using Computed Tomography Volumetry

Kazunari Sasaki, United States
Development and Validation of a Machine Learning Model to Reduce Futile Donation After Circulatory Death Procurements in Liver Transplantation

Kenji Okumura, United States
Development of a HIPAA Compliant Cloud-Based Donor Liver Biopsy Steatosis Assessment Tool Using Artificial Intelligence Technology

Agathe Truchot, France
Impact of Missing Data Imputation Strategies on Performances of Kidney Allograft Failure Prediction Models

16:30-17:45

10

16:30

Oral Abstract: Innovation in Pediatric Liver Transplant

Full Details

Amanda Jensen, United States
Age Matching Improves Graft Survival in Adolescent Liver Transplantation

Udeme Ekong, United States
Functional Phenotypic Diversity of Regulatory T Cells in Pediatric Liver Transplantation

Sarah Maxwell, United States
Health Outcomes in Children of Liver Transplant (LT) Recipients

Amanda Jensen, United States
Split Liver Transplantation Using Machine Perfusion in Pediatric Recipients

Nensi Ruzgar, United States
Disparities in Pediatric Liver Transplantation Based on Limited English Proficiency: Trends over 20 Years

Jennifer Halma, United States
Consensus Treatment Plans: A Novel Collaborative Effort to "Right Size" Immunosuppression After Pediatric Liver Transplant

16:30-17:45

12

16:30

Oral Abstract: Islet

Full Details

Balamurugan Appakalai, United States
Preserving Human Pancreatic Microvessel Fragments with Islets during Transplant Improved Islet Engraftment and Diabetes Reversal: Crosstalk Signaling Mechanisms That Regulate Intra-Islet Endothelial Cells Survival and Islet Microcirculation

Joseph Sushil Rao, United States
Clinical Scale Cryopreservation of Human Deceased Donor Islet and Stem Cell-Derived Beta Clusters by Vitrification for Allotransplantation in Type I Diabetes

qin yang, United States
Development of Non-Human Primate Stem Cell-Derived Islets for Allogeneic Transplantation

Bashoo Naziruddin, United States
Generation of Functional Islet Cell Organoids from Adult Multipotent Islet Progenitor Cells Captured during Islet Cell Isolation Procedures

qin yang, United States
Evaluation of Optimal Engraftment Sites for Human Stem Cell-Derived Islets in a Non-Human Primate Model

Catherine Parmentier, Canada
Simultaneous Islet-Kidney Transplantation as an Alternative for Patients Ineligible for Pancreas Transplant: Initial Experience at a North American Transplant Center

Meghan Hu, United States
A Comparison of Depletional Induction Strategies on Non-Human Primate Islet Xenotransplantation Outcomes

18:00-19:00

201

18:00

Town Hall: TTS Townhall

Full Details

John Fung, United States
Welcome & Overview

John Fung, United States
Select TTS Highlights

Randall Morris, United States
Randy Morris - TY

WTC 2025, Singapore
WHO Video

Medhat Askar, Qatar
WHO & TTS Highlights & Projects

Medhat Askar, Qatar
WHO & GDHC - Moving into the Future

07:00 - 08:00 | Early Morning Sessions

08:15 - 09:30 | Parallel Symposia

10:00 - 12:45 | Plenary Sessions

12:15 - 15:30 | Parallel Symposia

16:30 - 17:45 | Abstract Sessions

18:00 - 19:00 | Town Hall